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Osteoarthritis (OA) is the most common joint disease in humans. It affects the joint as a
whole and is characterized by progressive articular cartilage destruction, abnormal sub-
chondral bone remodelling, formation of osteophytes, ligament and periarticular muscle
weakening and in some cases synovial inflammation, which ultimately lead to a painful
and impaired joint. There are several known risk factors for the development of OA but
the exact sequence of events that lead to the destruction of the articular cartilage is not
yet fully understood.
Hereditary hemochromatosis (HH), a disease caused by mutations in the HFE gene,
is characterised by systemic iron overload, toxic accumulation of iron in parenchymal
cells of liver, heart, and endocrine glands. It is also associated with musculoskeletal
complications, namely an increased prevalence of OA. The role of iron overload in the
development of OA is still undefined.
To further understand the molecular mechanisms involved in the pathology of HH-
related OA, we surgically induced OA in the knee of a murine model of hereditary
hemochromatosis and studied the changes to cartilage and bone. Also, in order to un-
derstand how the different mutations in the HFE gene affect systemic iron overload
and related musculoskeletal complications, we studied the prevalence of musculoskeletal
complications in a cohort of patients with different HH genotypes.
Hfe-KO mice showed a systemic iron overload and an increased iron accumulation
in the knee synovial membrane following surgery. The histological OA score was signifi-
cantly higher in the Hfe-KO mice at 8 weeks after surgery. Micro-CT study of the proxi-
mal tibia revealed increased subchondral bone volume and increased trabecular thickness.
Gene expression and immunohistochemical analysis showed a significant increase in the
expression of matrix metallopeptidase 3 in the joints of Hfe-KO mice compared with
control mice at 8 weeks after surgery.
Among our cohort of HH patients the majority were homozygous for the C282Y mu-
tation. The serum ferritin concentration and serum transferrin saturation at diagnosis
were significantly higher in C282Y homozygous patients compared with those who were
compound heterozygous (C282Y/H63D). Also the overall prevalence of self-reported mus-
culoskeletal complications was significantly higher in patients with C282Y homozygosity.
The findings of this study suggest that systemic iron overload does not cause OA
directly but acts as a susceptibility factor. The systemic and synovial iron overload both
contribute to increase the catabolic response of the articular cartilage to mechanical
xix
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stress, accelerating the progression of the osteoarthritic disease process. Our findings
also suggests that the prevalence of musculoskeletal complications of HH is related to
the magnitude of the iron overload, since there was a greater prevalence of OA in the
homozygotes for the C282Y mutation, a genotype associated with higher systemic iron
overload.
Resumo
A osteoartrose (OA) é a patologia articular mais frequente nos humanos. Afecta a arti-
culação como um todo e as suas características principais são a destruição progressiva da
superfície articular, a remodelação anormal do osso subcondral, a formação de osteofitos,
o enfraquecimento das estruturas ligamentares, a atrofia muscular e, em alguns casos,
a inflamação da membrana sinovial. Todas estas alterações levam a uma articulação
dolorosa e incapaz de cumprir a sua função. Existem vários factores que aumentam o
risco de vir a desenvolver OA mas a sequência exacta de acontecimentos que levam à
destruição de uma articulação ainda não está totalmente esclarecida.
A Hemocromatose Hereditária (HH) é uma doença causada por mutações no gene
HFE e caracteriza-se por causar uma sobrecarga sistémica de ferro e acumulação tóxica
de ferro nas células parenquimatosas do fígado, do coração e das glândulas endócrinas.
Está também associada a uma maior prevalência de patologias do aparelho osteoarticular,
nomeadamente OA. Ainda não está definido qual o papel que a sobrecarga de ferro
desempenha na génese da OA secundária à HH.
Para melhor entender os mecanismos moleculares responsáveis pelo aparecimento da
OA secundária à HH, no decorrer do presente trabalho, foi induzida cirurgicamente OA
no joelho de um modelo murino de hemocromatose e foram estudadas as alterações
verificadas ao nível da cartilagem articular e do osso. Para além disso, para perceber
se as diferentes mutações no gene HFE influenciavam a sobrecarga sistémica de ferro e
as complicações osteoarticulares desta doença, foi estudada a prevalência de patologia
osteoarticular em coortes de doentes com diferentes genótipos de HH.
Os ratinhos Hfe-KO apresentaram uma sobrecarga sistémica de ferro e uma deposi-
ção aumentada de ferro na membrana sinovial do joelho após a cirurgia. Às 8 semanas
após cirurgia os ratinhos Hfe-KO apresentavam uma pontuação histológica da OA signi-
ficativamente superior aos seus controlos saudáveis, traduzindo-se numa maior degenera-
ção da cartilagem articular. Utilizando um aparelho de microtomografia computorizada
foi possível estudar as alterações do osso subcondral ao nível da tíbia proximal. Esta
apresentava-se com um volume ósseo aumentado e as trabéculas que a constituíam eram
mais espessas do que as do grupo de controlo. Ao nível da expressão genética e imu-
nohistoquímica observámos nos joelhos dos ratinhos Hfe-KO, um aumento significativo
da expressão da metaloproteinase da matriz 3.
No estudo das coortes de doentes com HH, a maioria dos doentes eram homozigóti-
cos para a mutação C282Y. A concentração de ferritina sérica e a saturação da trans-
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ferrina sérica na altura do diagnóstico eram significativamente mais altas no grupo dos
doentes homozigóticos quando comparadas com a dos doentes heterozigóticos compos-
tos (C282Y/H63D). Para além disso os doentes homozigóticos para a mutação C282Y
referiam uma maior prevalência de complicações osteoarticulares.
Os resultados deste estudo sugerem que a sobrecarga sistémica de ferro não é uma
causa direta de OA mas sim um factor que aumenta a vulnerabilidade das articulações
à sobrecarga mecânica. Supõe-se que a sobrecarga de ferro a nível sistémico e sinovial
aumenta a resposta catabólica da cartilagem articular ao stress mecânico, acelerando o
processo patológico da osteoartrose. Os dados obtidos sugerem ainda que a prevalência de
complicações osteoarticulares na HH está relacionada com a magnitude da sobrecarga de
ferro, uma vez que observámos uma maior prevalência de OA nos doentes homozigotos
para a mutação C282Y, um genótipo associado a uma maior sobrecarga sistémica de
ferro.
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Chapter 1
Introduction
Osteoarthritis (OA) is the most common joint disease in humans (Glyn-Jones et al.,
2015). It affects the joint as a whole and is characterized by progressive articular cartilage
destruction, abnormal subchondral bone remodelling, formation of osteophytes, ligament
and periarticular muscles weakening (Arden & Nevitt, 2006) and in some cases synovial
inflammation (Sellam & Berenbaum, 2010) that ultimately lead to a painful and impaired
joint.
1.1 Prevalence and incidence of osteoarthritis
Prevalence
Systematic autopsy studies report that cartilage lesions, subchondral sclerosis and osteo-
phytes are present in the knees of 60% of men and 70% of women aged over 70 (Arden
& Nevitt, 2006).
Large-scale population health surveys, measuring either radiographic or self-reported
OA (Table 1.1) provide current information about the prevalence of this disease. There is
considerable variation among studies, which may be due to different disease definitions,
anatomical locations and characteristics of the population sample such as age, genetic
background (Lawrence et al., 2008), occupation (O’Reilly et al., 2000) or environmental
exposures to toxins (Sun et al., 2012).
OA prevalence increases indefinitely with age, and it is estimated that up to 8% of
adults aged 25 and older in the United States of America have clinical OA of some joint
(Lawrence et al., 2008). Worldwide OA affects 9.6% of men and 18% of women aged
>60 years (Woolf & Pfleger, 2003). It is the sixth leading cause of disability-adjusted
life years (DALYs) accounting for 3% of the total global DALYs (Woolf & Pfleger, 2003)
and it is projected that in high-income countries this figure will remain similar until 2030
(Mathers & Loncar, 2006).
1
2 CHAPTER 1. INTRODUCTION
Table 1.1: Prevalence of osteoarthritis in large-scale surveys. National Health and
Nutrition Examination Survey (NHANES);
Source Age Population Site Criteria Overall %




(Felson et al., 1987) >63 Framingham,
USA
Knee Radiographic 33 %
Symptomatic 9.5%




















(Vavken & Dorotka, 2011) >15 Austria Entire body Self-reported 18.8%
Incidence
The incidence of OA depends on the disease process that initiated the cartilage degen-
eration. Since it is impossible to know for certain the onset of the disease process, most
of the studies base their results on radiographic criteria to assess the incidence and pro-
gression of OA, giving a skewed estimate of the true incidence of this disease. Also most
of the incidence rates reported reflect a mix of primary and secondary OA.
Estimates from the Australian population suggest that osteoarthritis affects women
more frequently than men across all age groups (2.9 per 1000 vs. 1.7 per 1000) (Mathers
et al., 1999), findings corroborated by other authors in a meta-analysis (Srikanth et al.,
2005). The incidence of radiographic disease is higher than of symptomatic OA (Felson
et al., 1995) but both increase with age, approaching 1% per year for symptomatic knee
OA in elderly females (Oliveria et al., 1995) and 2.5% per year for radiographic knee OA
in individuals of both sexes aged >55 years (Cooper et al., 2000).
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1.2 Causes of osteoarthritis
Usually, OA is classified as primary (idiopathic) or secondary, according to the mechanism
that initiates the cartilage degradation (Ferri, 2015).
Primary OA is considered a process that occurs with ageing and normal usage of the
joint. However, some authors defend that this classification is not valid, and that all OA
is secondary (Brandt et al., 2009a), since the degenerative process derives from either an
abnormal joint structure or an abnormal distribution of force across the different joint
tissues (Murray, 1965; Solomon, 1976; Mitchell & Cruess, 1977). In this context, primary
OA could be classified as a case of normal forces acting on an abnormal joint structure.
Indeed, the ageing process leads to chondrocyte senescence undermining their ability
to maintain the cartilage matrix (Martin et al., 2004) and causing a decrease in matrix
proteoglycan content. This is accompanied by a decrease in water content, altering the
force-absorbing characteristics of the cartilage, making it more susceptible to degenera-
tion from normal joint use (Buckwalter et al., 2005).
Several disorders cause direct or indirect damage to articular cartilage leading to
joint degeneration (Buckwalter & Mankin, 1998). A brief summary of these conditions is
presented in Table 1.2. The presumed mechanisms leading to OA development are either
damage to articular cartilage or alterations to joint alignment, congruity or stability that
eventually lead to joint degeneration.
Since the focus of this dissertation is the role of iron overload in the development
of OA, the relationship between Hereditary Hemochromatosis (HH) and OA will be
described in more detail.
Table 1.2: Causes of secondary OA and their presumed initiating mechanism
Cause Presumed Mechanism
Acute trauma (Intra-articular fracture,
joint surgery)
Damage to articular cartilage or incongruity of
joint or both
Chronic joint overload (sports, occupa-
tional)
Damage to articular cartilage or subchondral
bone or joint incongruity
Hemochromatosis Mechanism unknown
Inflammatory arthritis Synovial membrane inflammation induces bone,
ligament and cartilage destruction
Ochronosis Deposition of homogentisic acid polymers in ar-
ticular cartilage
Gaucher’s disease Bone necrosis or pathological fracture leads to
incongruity of joint
Dysplasia of joint and cartilage (develop-
mental or congenital)
Abnormal shape of the joint or abnormal articu-
lar cartilage or both
Acromegaly Overgrowth of cartilage produces joint incon-
gruity
Calcium pyrophosphate deposition disease Accumulation of crystals in articular cartilage
Infection of joint Destruction of articular cartilage
4 CHAPTER 1. INTRODUCTION
Table 1.2: Causes of secondary OA, cont.
Cause Presumed Mechanism
Neuropathic arthropathy (Charcot joints
due to diabetes mellitus, syphilis, sy-
ringomyelia, myelomeningocele, amyloido-
sis)
Loss of proprioception and joint sensation
Avascular necrosis Bone necrosis leads to collapse of the articular
surface and incongruity of the joint
Hemophilia Recurrent hemarthroses leads to proliferative
synovitis and cartilage degradation
Ligament injuries Instability of the joint
1.3 Hemochromatosis
1.3.1 Characteristics and molecular causes
There are at least five recognised subtypes of hemochromatosis (Table 1.3), each with
distinct genetic and molecular profiles (Kanwar & Kowdley, 2013). These can be grouped
into those associated to hemochromatosis (HFE) gene mutations and those independent
of HFE gene mutations, with the latter being more relevant in the Asia-Pacific popu-
lations. We will focus on the Type I, or classical hemochromatosis, resulting from the
mutation of the HFE gene, since it is the most common type on the European population.
Hereditary hemochromatosis (HH) (Figure 1.1) is an autosomal recessive disorder
characterized by increased absorption of dietary iron, and rapid iron release from intra-
cellular storage sites, which leads to abnormal accumulation of iron in several organs,
particularly in the liver, heart, endocrine organs and joints (Allen et al., 2008; Guggen-
buhl et al., 2011b). Large-scale screening studies in populations of Northern European
descent have estimated that the prevalence of the disease is 0.5 to 11.5 per 1,000 persons
and that it affects predominantly males (Tanner et al., 1985; Karlsson et al., 1988; Ed-
wards et al., 1988; Leggett et al., 1990; Phatak et al., 1998; Asberg et al., 2001; Steinberg
et al., 2001), making it one of the most common genetic disorders among caucasians.
Trousseau (Trousseau, 1865) originally reported the triad of cirrhosis, diabetes and
skin tanning, and Von Recklinghausen completed the description, reporting the presence
of strong iron deposits within the liver of those patients, suggesting that iron played a
central role in the development of the disease (Von Recklinghausen, 1889).
The research around this disease continued, but it was only in 1977 that Simon et al.
were able to link it to a region in chromosome 6, close to the human leukocyte antigen
(HLA) genes (Simon et al., 1977).
More recently the role of genetic factors was elucidated when Feder (Feder et al.,
1996) identified two missense alterations: cysteine-to-tyrosine substitution at amino acid
282 (C282Y) and histidine-to-aspartic acid substitution at position 63 (H63D), in an
major histocompatibility complex (MHC) class I-like gene in 83% of their HH patients.
The gene was then named HFE and follow-up studies showed that these mutations
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Figure 1.1: Iron metabolism in healthy patients and in hemochromatosis. Adapted
from P. C. Adams and J. C. Barton. Haemochromatosis. Lancet, 370(9602):1855–60,
Dec 2007.
affected the ability of the HFE protein to interact with the transferrin receptor (Waheed
et al., 1997; Feder et al., 1998), thus failing to form the membrane-associated iron-sensing
complex composed of HFE, transferrin receptor 2 (TFR2) and hemojuvelin (HJV). That,
in turn, leads to low levels of hepcidin antimicrobial peptide (HAMP) transcription (Bri-
dle et al., 2003; Giannetti & Björkman, 2004; Waheed et al., 2008; Schmidt et al., 2008;
D’Alessio et al., 2012).
HAMP is the main regulator of iron homeostasis (Viatte & Vaulont, 2009). It is a
peptide produced by the liver in response to anaemia, hypoxia and inflammation (Nicolas
et al., 2002) and acts by inducing the degradation of the iron-exporter protein ferroportin
(FPN) (Nemeth et al., 2004). The HAMP mediated internalization and degradation of
FPN causes intracellular iron retention in enterocytes, macrophages and hepatocytes,
lowering blood serum iron levels (Pantopoulos et al., 2012). Inversely the lack of HAMP
causes a release of iron from intracellular storage and consequent systemic iron overload
and clinical disease (Ganz, 2013).
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Table 1.3: Types of hereditary hemochromatosis, adapted from D. Ekanayake et al. ,
Recent advances in hemochromatosis: a 2015 update, Hepatol Int, Apr 2015
Type Gene Function Prevalence Associated features








Type IIA HJV Upregulates hep-
cidin
Rare; more com-
mon than type IIB
Severe early onset
Type IIB HAMP Inhibits iron up-
take by enterocyte
Rare







in Italy and Brazil.
Can have juvenile or
adult onset. Most
cases are adult and
have a more severe
course than type I.
Type IV FPN Iron export Rare Reduced end-organ
damage
1.3.2 Clinical presentation
Classical hemochromatosis usually manifests itself in middle-aged patients and the signs
can range from simple biochemical abnormalities such as elevated serum ferritin to severe
organ damage and disease (Pietrangelo, 2010). The variations in signs and symptoms
occur because the HFE mutations only predispose the individual to hemochromatosis;
additional factors such as simultaneous mutations in other genes, gender, alcohol intake,
obesity and concomitant liver disease are required (Olynyk et al., 1999). Some organs
such as heart, liver, pancreas, pituitary gland and joints, are more readily affected by the
iron overload (Bacon & Sadiq, 1997). The classic presentation of liver cirrhosis, bronze-
colored skin, diabetes, heart disease and joint inflammation is rare nowadays, due to
the increased awareness for the disease and better screening programs (Ekanayake et al.,
2015). Most of the patients nowadays present nonspecific symptoms such as weakness,
lethargy, arthralgia, and also unspecific signs such as hepatomegaly. The transferrin
saturation is frequently elevated and, in later stages of the disease, the serum ferritin
also increases, indicating iron deposition in soft tissues (Pietrangelo, 2010). Patients
with serum ferritin levels >1000µg l 1 at diagnosis have an increased risk of cirrhosis and
death (Barton et al., 2012).
1.3.3 Diagnosis
Diagnosis is made by a combination of clinical features, laboratory tests, imaging and
genetic testing. Universal screening for HH is not recommended but, if a patient is
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symptomatic, has hyperferritinemia or a first degree relative with hemochromatosis, de-
termination of transferrin saturation and of serum ferritin levels is indicated (Crownover
& Covey, 2013).
After ruling out other causes that affect body iron levels and other causes of liver
damage such as viral and alcoholic hepatitis, a transferrin saturation >45% and ferritin
levels >300µg l 1 in men or >200µg l 1 in women, is a strong indication for HFE genetic
screening (Crownover & Covey, 2013). Homozygotes for C282Y mutation with elevated
iron parameters do not need a confirmatory biopsy and can start treatment. Patients
with other HFE genotypes should undergo a liver biopsy to assess the need for treatment.
Liver biopsy is the best determinant of fibrosis and cirrhosis and it has a great value
in determining patient prognosis. An hepatic iron concentration (HIC) >4000 µg is diag-
nostic of HH phenotype and is a formal indication to begin treatment with phlebotomy
(Kanwar & Kowdley, 2014).
With the advent of less invasive methods for measuring HIC such as T2* magnetic
resonance imaging (MRI) (St Pierre et al., 2005) and for staging liver disease such as
transient elastography (Adhoute et al., 2008), the necessity to perform a liver biopsy is
diminishing.
1.3.4 Treatment
Once the disease is diagnosed a treatment or surveillance protocol is initiated. For
patients with serum ferritin in the normal range a yearly follow-up with transferrin
saturation and serum ferritin measurement suffices (European Association For The Study
Of The Liver, 2010).
If the ferritin levels are elevated, treatment with phlebotomy, in order to bring serum
ferritin to a level between 50 µg l 1 and 100 µg l 1, is indicated (European Association
For The Study Of The Liver, 2010).
Phlebotomy is the only widely accepted treatment. It works by directly reducing the
haemoglobin stores of iron and by inducing erythropoiesis, which mobilises stored iron
(Ekanayake et al., 2015). Even though no randomised trial documented the efficacy of
this treatment, it is known that it has beneficial effects in some symptoms of the disease.
Treatment with iron chelators or with erythrocytapheresis have been described in the
literature (Kanwar & Kowdley, 2014).
Liver transplantation is a curative treatment option, and post-transplant outcomes
are comparable with other diagnoses. However, when compared to phlebotomy, it has a
much higher cost and entails chronic immunosuppression (Bardou-Jacquet et al., 2014).
1.3.5 Hemochromatosis and arthropathy
The first description of HH-related arthropathy is attributed to Schumacher, who re-
ported the cases of two patients with an early-onset arthritis closely associated with the
other symptoms of hemochromatosis, and with greater involvement of proximal interpha-
langeal and metacarpal-phalangeal joints (Schumacher, 1964). These patients also had
hemosiderin in the synovial lining cells, without proliferative or inflammatory changes.
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At the time Schumacher speculated that iron could act as a toxin causing physical or
metabolic alterations in the cartilage.
Since the original description, several studies have focused on the prevalence of mus-
culoskeletal complications in hemochromatosis, reporting (i) an increased prevalence of
joint pain and arthritis (McDonnell et al., 1999; Richette et al., 2010; Sahinbegovic
et al., 2010b) and (ii)increased rates of joint replacement surgery (Sahinbegovic et al.,
2010a; Wang et al., 2012; Elmberg et al., 2013) in patients with mutations of the HFE
gene. However, the mechanism by which iron overload damages the joints in HH is still
undefined.
Histological studies of synovial tissue in HH-related arthritis show superficial de-
posits of hemosiderin, minor proliferation of synovial cells, and less inflammatory cell
infiltrate when compared to rheumatoid arthritis (Muirden & Senator, 1968), but more
macrophages and neutrophils when compared to primary OA (Heiland et al., 2010). The
latter study suggests that the increased accumulation of neutrophils may lead to produc-
tion of matrix-degrading enzymes causing cartilage degradation. Another study (Carroll
et al., 2010) found a two to threefold increased ferritin concentration in the synovial fluid
of OA patients who were heterozygous for HFE gene mutations, compared to patients
without any HFE mutation, but they found no differences in the concentration of selected
inflammatory cytokines or matrix metallopeptidase 3 (MMP3) between the two groups.
Patients with HH were found to have increased non-transferrin bound iron (NTBI)
concentrations in serum (de Valk et al., 2000). This potentially toxic iron form could also
be present in excess in the joints of HH patients and cause cellular damage to synovial
membrane and chondrocytes due to its propensity for generating reactive oxygen species
(ROS) (Brissot et al., 2012).
In conclusion, while significant progress has been made in understanding the molecu-
lar mechanisms of iron overload in HH the pathogenesis of HH-related OA is still poorly
understood (Husar-Memmer et al., 2014).
1.4 Pathogenesis of osteoarthritis and tissues affected
Osteoarthritis is the pathophysiological response of a synovial joint to insult, either me-
chanical, metabolic or inflammatory (Brandt et al., 2009b). It is a disease of the joint as
a whole, meaning that lesions in either cartilage, bone, ligaments, synovial membrane or
periarticular muscles can ultimately lead to the destruction of the extracellular matrix of
articular cartilage, subchondral bone sclerosis, osteophyte formation, joint effusion and
loss of function (Figure 1.2).
The chondrocytes are responsible for the synthesis and maintenance of the articular
extracellular matrix (ECM) (Muir, 1995). Their metabolism, and subsequent articular
cartilage growth and function, is influenced by mechanical stimuli (Lee et al., 2000;
Bougault et al., 2012) and by mediators from the synovial membrane (Pelletier et al.,
1985) reinforcing the notion that OA is not only a disease of the articular cartilage but
of the whole joint.
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Figure 1.2: Structural changes and selected signalling and effector molecules in the
development of osteoarthritis. ADAMTS: a disintegrin and metalloproteinase with
thrombospondin-like motifs; IL: interleukin; MMP: matrix mettaloproteinase; TGF:
transforming growth factor; TNF: tumor necrosis factor.Adapted from S. Glyn-Jones
et al.Osteoarthritis. Lancet, Mar 2015
Changes to cartilage
Articular hyaline cartilage is mainly constituted by a mesh of type II collagen fibres,
stabilised by other collagen types and non-collagenous proteins, which provide shear and
tensile strength to the cartilage. Hyaluronic acid and proteoglycans are embedded in
this structure and they retain water in the cartilage providing compressive resistance
(Glyn-Jones et al., 2015). Water is the most abundant component of articular cartilage
and most of it is contained within the intrafibrillar space of the matrix, held in place by
the negative charge of the proteoglycans (Pearle et al., 2005).
Chondrocytes, which are highly differentiated cells, have a limited capacity for pro-
liferation or migration since they are encased in this dense extracellular matrix. In the
event of a lesion, they are unable to reach the damaged areas and the matrix components
that they would produce cannot fill the extracellular matrix (ECM) defects (Buckwalter
et al., 2005). Although chondrocytes synthesise sufficient macromolecules to maintain
the structure of the ECM, their capacity to further increase the synthesis of proteoglycans
or collagen is limited and insufficient to repair a significant tissue defect (Muir, 1995).
Another obstacle to the repair of articular lesions is that adult articular cartilage is a
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dense and avascular tissue. Therefore disruption of the tissue does not cause fibrin clot
formation or migration of undifferentiated cells to the site of tissue damage, where they
could then proliferate, differentiate and synthesise a new matrix.
The progression of the cartilage damage occurs in three overlapping phases: damage
to the chondrocytes or to the extracellular matrix, chondrocyte response to the insult,
and the decline of chondrocyte anabolic processes and eventual loss of cartilage tissue.
The initial damage can result from several causes (Table 1.2), but most frequently results
from a mechanical insult.
The damage to the collagen network, which usually begins in the superficial layer
of the cartilage, is accompanied by loss of the articular cartilage proteoglycans (Radin
et al., 1973; Squires et al., 2003). This disrupts the extracellular matrix framework,
increasing the permeability and decreasing the tensile strength of the tissue (Bank et al.,
2000), allowing the proteoglycans to expand and increasing the water concentration of the
extracellular matrix (Inerot et al., 1978). These alterations of the cartilage are clinically
referred to as chondromalacia, and are accompanied by fibrillation of the surface layer,
predisposing the remaining cartilage to further mechanical insult (Setton et al., 1993).
These high-strain mechanical stimuli that act on the chondrocytes are transduced by
mechanosensitive ion channels leading to biochemical-metabolic responses (Lee et al.,
2014).
One of the responses to mechanical stress is increased production of nitric oxide
(NO), an inflammatory mediator, (Fermor et al., 2002) which increases apoptosis (Blanco
et al., 1995), and leads to a decrease in chondrocytes proteoglycan production, replicative
capacity and telomere length (Yudoh et al., 2005). Mechanical insult also induces the
expression of genes encoding for several collagenases (metallopeptidase 1, 3 and 13),
and aggrecan-degrading enzymes(ADAMTS 4 and 5) (Lee et al., 2005; Burleigh et al.,
2012), resulting in degradation of the collagen network and of the proteoglycan structure,
further weakening the mechanical properties of articular cartilage. There is a small repair
component associated with this stage of OA, with an increase in proteoglycan (Venn
et al., 1995) and type II collagen (Hermansson et al., 2004) synthesis, and chondrocyte
proliferation (De Ceuninck et al., 2001). If the insult to the cartilage is maintained the
cartilage damage will progress since newly synthesised proteoglycans will fail to aggregate
(Moskowitz et al., 1979) and the type II collagen will not be incorporated in the existing
collagen network (Buckwalter et al., 2005).
The final stage of OA occurs when cartilage is unable to recover from the mechanical
and chemical insults, resulting in chondrocyte hypertrophy, calcification of the ECM,
and complete destruction of the articular cartilage (van der Kraan & van den Berg,
2012). With ageing, the chondrocytes are less responsive to anabolic growth factors,
and synthesise smaller and less functional proteoglycans (Martin & Buckwalter, 2003).
In addition there is an accumulation of advanced glycation end-products that affect the
mechanical properties of the ECM (Shane Anderson & Loeser, 2010), thus OA is more
commonly seen in the elderly.
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Changes to subchondral bone
Articular cartilage is seated on a subchondral plate, a thin layer of cortical bone supported
by the trabecular bone of the metaphysis. Articular cartilage is too thin to effectively
absorb the shock of impulsive loads. The bone and soft tissues attenuate these forces far
better (Radin & Paul, 1970).
The subchondral bone acts as a cushion to dampen the forces acting upon the articular
cartilage, and the probable mechanism for shock absorption is limited trabecular fracture
(Simon et al., 1972). This would result in the formation of a fracture callus and increased
remodelling of the subchondral bone (Radin & Rose, 1986; Hayami et al., 2004).
The remodelling process caused by repetitive and unattenuated impulsive loads leads
to increased trabecular thickness and reduced size and number of the intertrabecular
spaces, resulting in sclerosis and stiffening of the subchondral plate (Radin et al., 1991).
With MRI imaging it is possible to detect bone-marrow lesions related to trabecular
microfractures at different stages of healing that are localized in the areas with most
cartilage damage (Taljanovic et al., 2008). Some authors (Imai et al., 1989; Brandt
et al., 2009b) propose that the rigid subchondral bone increases the shear stress at the
cartilage/bone interface, causing splitting between the layers of bone and cartilage which
results in cartilage degeneration. Conversely, loss of cartilage integrity could lead to
increased loading of the subchondral bone and subsequent remodelling (Brandt et al.,
2009b). The exact sequence of events is still undefined. Features of endochondral os-
sification such as chondrocyte hypertrophy, cartilage degradation and vascular invasion
are replayed in osteoarthritis, resulting in tidemark advances (Oegema et al., 1997) and
osteophyte formation (Moskowitz & Goldberg, 1987; Hashimoto et al., 2002). These os-
teophytes can restrict joint motion and be a source of pain at the limits of joint motion.
Changes to periarticular tissues
The cells in the synovial membrane produce the synovial fluid, which contributes to
cartilage nourishment, and lubricates and protects the articular surfaces. Synovial fluid
includes lubricants such as hyaluronic acid (HA) (Smith & Ghosh, 1987) and lubricin
(Jay et al., 2007), but in patients with OA the lubrication capability of the synovial fluid
is diminished (Ludwig et al., 2012), possibly owing to lower concentration and lower
molecular mass of the HA (Moreland, 2003).
The cartilage and subchondral bone degradation products found on OA act on the
synovial membrane, leading to a persistent low grade synovitis (Brandt et al., 2009a),
and resulting in the production of proinflammatory cytokines, such as interleukin 1 (IL1)
and tumour necrosis factor a (TNF-a) (Smith et al., 1997). These cytokines are released
into the synovial fluid and act on the chondrocytes by inducing the biosynthesis of NO
(Stadler et al., 1991). In turn this results in reduced proteoglycan synthesis (Taskiran
et al., 1994), reduced type II collagen synthesis (Goldring et al., 1988), and activation
of metalloprotease activity (Murrell et al., 1995), with the end result being damage
to the articular cartilage. In the late stages of OA there is also a contracture of the
articular capsule and ligaments resulting in a decreased range of motion. Periarticular
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muscle atrophy can also be seen in late-stage OA, since joint pain leads to decreased
mobilization causing secondary muscular atrophy.
1.5 Risk factors for osteoarthritis
Mechanical overload of the joint not only literally crushes the articular cartilage and
subchondral bone (Brandt et al., 2009b),but also leads to the expression of proteases that
cause ECM degradation (Burleigh et al., 2012). Not all joints subjected to mechanical
overload develop OA. Follow-up studies of patients with anterior cruciate ligament or
meniscus tears, report that 20 years after the diagnosis, the prevalence of OA was on
average 50% (Lohmander et al., 2007). This was also observed among subjects with
paediatric orthopaedic hip conditions in whom the prevalence of hip OA 30 years after
the diagnosis is 60-70% (Weinstein, 2000).
Although this does not mean that the patients which did not develop OA will not
develop it in the future, it reinforces the hypothesis that there are other factors that are
likely to contribute to the development of OA, namely environment (Hunter et al., 2002),
gender (Yoshimura et al., 2009), diet (La Grange et al., 2001) and genetics (Tsezou, 2014).
From the biomechanical point of view several factors can cause mechanical overload
of the joint, with the most common being joint incongruity, joint instability, loss of limb
alignment, diminished muscle strength or excess body weight. Each of these will now be
briefly described.
Joint incongruity
Joint incongruity may arise from intra-articular fractures (Marsh et al., 2002; Murray
et al., 2004); from congenital abnormalities such as hip dysplasia (Jacobsen & Sonne-
Holm, 2005); from osteonecrosis of the femoral head (Ohzono et al., 1991), humeral head
(Hasan & Romeo, 2002) or femoral condyles (Lotke & Ecker, 1988); from meniscectomy
(Roos et al., 1998) or from altered geometry of the metaphysis such as femoroacetabular
impingement (Ganz et al., 2003), among other causes. It results in abnormal load distri-
bution within the joint and is associated with a very high risk of developing osteoarthritis
of the affected joint.
Joint instability
Experimental data has shown that joint instability causes an abnormal distribution of
forces across the articular cartilage (Papageorgiou et al., 2001), leading to extracellular
matrix lesions and subsequent cartilage degeneration (Kamekura et al., 2005).
Traumatic injuries that cause ligamentous injury can also cause intra-articular bleed-
ing, meniscal or osteochondral lesions and damage the articular capsule and peri-articular
muscles. These associated lesions may contribute to OA development in unstable joints
(Roos, 2005; Øiestad et al., 2009). Clinical studies on the natural history of joint insta-
bility show an increased incidence of knee OA in patients with anterior cruciate ligament
insufficiency (Kannus & Järvinen, 1989; Hill et al., 2005), of shoulder OA in patients with
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massive rotator cuff tears (Neer et al., 1983) or traumatic anterior instability (Buscayret
et al., 2004) and of ankle OA in patients with traumatic ligament injury (Valderrabano
et al., 2006).
Limb alignment
In the lower limb, the ground reaction force is transmitted across a linear axis extend-
ing from the centre of the hip to the centre of the talus, which is often referred to as
the load-bearing axis (LBA). The hip-knee-ankle (HKA) angle describes how closely the
mechanical axes of the femur and tibia are lined up with each other. Perfect alignment
would have the femoral and tibial long axes in line with each other. Surveys show that
in healthy adults the HKA is 1º varus (Cooke et al., 1997) positioning the knee centre
marginally lateral to the LBA, causing 60-70% of the ground reaction force to be trans-
mitted through the medial compartment (Andriacchi, 1994). The increased compressive
stress is associated with increased incidence and progression of knee OA (Sharma et al.,
2010), and this could explain the greater prevalence of medial compartment involvement
in OA(McAlindon et al., 1992).
Muscle strength
The quadriceps is the main muscle of the anterior compartment of the thigh and acts as
a brake, decelerating the descent of the leg during the swing phase of gait. Quadriceps
weakness (Slemenda et al., 1997) and atrophy (Fink et al., 2007) are common clinical
findings in patients with knee OA, but little is known about why it develops.
One hypothesis is that diseased joints, due to altered proprioception or pain, transmit
afferent inputs that inhibit the motor neuron stimulation (Rutherford et al., 1986) causing
a diminished quadriceps muscle activation (Lewek et al., 2004). This leads to altered
movements when walking and to different patterns of muscle activation in the lower
limb, particulary an imbalance between the quadriceps and the hamstring (Hortobágyi
et al., 2005), which may interfere with the joint’s ability to dissipate the forces arising
from contact with the ground, ultimately contributing to OA progression (Childs et al.,
2004).
Individuals with hip OA also exhibit a decrease in the cross-sectional areas and
strength of pelvic and thigh muscles, when compared to healthy age-matched controls
(Arokoski et al., 2002) making it clear that alterations in muscle function are not limited
to the knee. Muscle strength is also associated with the initiation of hand OA, but it
seems to have an inversed effect, in that, men with high grip strength are at increased
risk for developing hand OA (Chaisson et al., 1999).
Age and gender
Age is the biggest risk factor for the development of OA (van Saase et al., 1989; Felson
et al., 2000; Lawrence et al., 2008). While the exact mechanism is not clear, it could
reflect an accumulation of biomechanical insults, senescence of articular chondrocytes
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with corresponding decline in function (Martin et al., 2004), or a reduced capacity to
respond to biomechanical stresses owing to age-related decrease in neuromuscular joint
protective mechanisms (Mau-Moeller et al., 2013; Maden-Wilkinson et al., 2014), or a
combination of all these factors. Osteoarthritis is more common in women than in men
(Lawrence et al., 2008). The role of oestrogen in the development and symptoms of OA
in humans is still undefined (Nevitt et al., 2001), but a recent study found evidence that
in mice, testosterone accelerated the progression of surgically induced OA (Ma et al.,
2007) suggesting that chondrocyte metabolism may be influenced by hormones.
Genetic background
Osteoarthritis seems to have a genetic basis, as pointed out by genome-wide associa-
tion studies which have found several genes to be differentially expressed between cases
and controls, namely up-regulation of the apoptosis pathway (Ramos et al., 2014), up-
regulation of the Wnt pathway (Velasco et al., 2010) and down-regulation of oxidative
defence genes (Aigner et al., 2006). These large scale genome-wide studies also identified
several loci associated with increased OA susceptibility (Kerkhof et al., 2010; Demirkan
et al., 2012; Evangelou et al., 2014), but the molecular mechanisms by which each of
these genetic variations increase OA risk are still not clear (Tsezou, 2014).
Bone mineral density
Increased bone mineral density (BMD) has been identified as a potential risk factor for
hip and knee OA in several epidemiological studies (Hannan et al., 1993; Burger et al.,
1996; Hochberg et al., 2004; Hardcastle et al., 2015). While the association between
radiographically diagnosed OA and increased BMD is widely accepted, it is possible
that confounding factors such as activity levels or bone size may explain this association
(Javaid & Arden, 2013). In addition, increased BMD is more strongly related to the
presence of osteophytes than to joint space narrowing (Nevitt et al., 1995), suggesting
that increase BMD may predispose to the bony features of OA (appearance of osteophytes
and subchondral sclerosis) rather than directly to cartilage loss (Hardcastle et al., 2014).
Since most epidemiological studies use the Kellgren-Lawrence (KL) criteria, in which
osteophytes are considered as a radiographic sign of OA (Schiphof et al., 2008), the bony
features of OA seen in individuals with increased BMD would lead to a diagnosis of
radiographic OA, yet cartilage damage could in fact be minimal.
Obesity
Weight gain is strongly associated with increased progression of cartilage damage (Buc-
knor et al., 2015), and obesity is a well-established risk factor for knee OA (Hochberg
et al., 1995; Oliveria et al., 1999), although the effect could also depend on knee alignment
(Felson et al., 2004), but does not increase the risk of developing hip OA (Mork et al.,
2012). The primary mechanism for this association probably involves the mechanical
overload of the knee joints during weight-bearing activities, causing damage to carti-
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lage and ligaments. Quadriceps muscle strength seems to be maintained in the obese
individuals at risk for knee OA (Segal et al., 2011). Metabolic alterations associated
with obesity, namely hyperglycaemia, raised triglycerides, hypertension or reduced high-
density lipoproteins are also associated with an increased risk of OA (Monira Hussain
et al., 2014). Cartilage metabolism could also be altered in obese individuals, explaining
the increased prevalence and incidence of OA in non-weight bearing joints, such as hand
and wrist, in obese individuals (Carman et al., 1994).
Diet
Oxidative damage to cartilage and periarticular tissues caused by reactive oxygen species
could increase the susceptibility to OA (Afonso et al., 2007), so an increased intake of
antioxidants might be associated with a lower rate of OA (McAlindon et al., 1996a).
Longitudinal population studies found a reduced progression rate of knee OA in indi-
viduals with a high reported intake of vitamin C (McAlindon et al., 1996a; Peregoy &
Wilder, 2011), but a more recent study found that individuals who were in the highest
tertile of circulating vitamin C levels had an increased incidence of radiographic knee
osteoarthritis, and similar results were found for circulating vitamin E levels (Chaganti
et al., 2014).
Vitamin D metabolites influence the development and maturation of calcifying car-
tilage (Schwartz et al., 1989), and it has been postulated that low levels of vitamin D
could increase the risk of incident hip and knee OA (McAlindon et al., 1996b; Lane et al.,
1999), however a large longitudinal study (Felson et al., 2007) and a randomized clinical
trial(McAlindon et al., 2013) both found that vitamin D supplementation failed to reduce
knee pain or OA progression.
Kashin-Beck disease (KBD) is a condition that affects the chondrocytes of the articu-
lar cartilage and growth plate, leading to secondary deformities of the long bones and to
cartilage degeneration (Kolsteren, 1992). While the aetiology is unknown, several studies
show a relationship with selenium (Sun et al., 2012; Zhang et al., 2011) and iodine (Yao
et al., 2011) deficiencies, mycotoxins on grain (Liu et al., 2014), and the presence of
organic material in drinking water (La Grange et al., 2001) reinforcing the importance
of nutrients in the pathogenesis of OA.
Occupation and physical activity
Mechanical overload of joints caused by repetitive motions could lead to OA. Occupations
such as construction work and mining, which require repetitive knee-bending and heavy
lifting, have been associated with knee OA in a middle-aged working population (Ander-
son & Felson, 1988; O’Reilly et al., 2000). Hand OA was also associated with occupations
demanding increased manual dexterity, such as cleaning work, clothing industry works
and masonry (Rossignol et al., 2005).
Physical activity is potentially detrimental to the joint should it lead to repetitive
overload, namely in individuals presenting with joint instability, abnormal limb alignment
or sports-related injuries (Buckwalter & Lane, 1997). Moreover, there is an increased risk
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of hip and knee OA among former elite athletes when compared to untrained controls
(Marti et al., 1989; Kujala et al., 1994) and to non-elite athletes (Lindberg et al., 1993;
Roos et al., 1994), but for most individuals practising recreational sports at a normal
level there is no increased risk of developing OA (Lequesne et al., 1997). It is still unclear
if the increased prevalence of OA in elite athletes is related with high-intensity loading
of the joints or if it is secondary to an increased prevalence of joint injuries (Hunter &
Eckstein, 2009).
1.6 Diagnosis of osteoarthritis
Osteoarthritis is classically diagnosed by clinical examination and plain film radiographs.
Patients in the early phases of OA usually have minimal signs and symptoms, but there
may be discrete loss of motion at the extremes or soreness after excessive exercise that
resolves with a few days of rest or anti-inflammatory medication. With the progression of
the disease the symptoms can aggravate. There will be pain with ordinary daily activities,
and physical examination will reveal joint pain, loss of motion, crepitus, deformity and
joint effusion. By this stage the disease is probably irreversible. Symptoms fluctuate
with time and are influenced by comorbid pathologies. Patients usually only seek medical
attention when symptoms affect their daily lives, and the fluctuating course hinders the
diagnosis of the disease in its early stages.
The features of osteoarthritis seen in plain radiographs include joint space narrowing,
osteophyte formation and the development of subchondral sclerosis and cysts (Keyes
et al., 1992). Scoring systems for OA features in plain radiographs include those proposed
by Kellgren and Lawrence (Kellgren & Lawrence, 1957), by Ahlbäck (Ahlbäck, 1968)
and by the Osteoarthritis Research Society International (OARSI) (Altman & Gold,
2007). When compared to newer imaging modalities such as MRI, plain radiographs
lack sensitivity and cannot detect localized cartilage damage (Kim et al., 2003). Also the
radiographic findings in plain radiographs may not correlate adequately with the severity
of the symptoms (Creamer et al., 2000). Nevertheless, plain radiographs are inexpensive
and readily available, making them very useful in clinical and research settings.
Newer MRI techniques such as delayed gadolinium-enhanced MRI of the cartilage
(dGEMRIC), T1rho, sodium MRI, T2 mapping and (Jazrawi et al., 2011) are currently
being used to study the early stages of OA. Physiological MRI methods such as dGEM-
RIC allow us to study the glycosaminoglycan (GAG) concentration of cartilage (Kim
et al., 2003) and have a good correlation with the histological grade of osteoarthritis
(Zilkens et al., 2013) and with the development of future knee OA (Owman et al., 2008).
The main downsides of this technique are the long scan times and the use of high doses
of intravenous nephrotoxic contrast agent (Marckmann et al., 2006). Advantages of T2
mapping are that it does not require contrast, has acceptable scanning times, and its
values are correlated with histological changes (Nishioka et al., 2012). Moreover, the
addition of a T2 mapping sequence to a routine MRI improves the detection of knee
cartilage lesions (Kijowski et al., 2013).
There are several systems for grading histological changes in OA, the most widely
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used being the Mankin (Mankin et al., 1971) score system and the OARSI (Pritzker et al.,
2006). These systems focus on cellular changes, proteoglycan content and architectural
changes of the articular cartilage (fissures, erosion, osteophyte formation). Since they
rely on a tissue biopsy of the affected joint, and require a specialized and time-consuming
tissue processing, their usefulness in the clinical setting is limited, being more often used
in the research setting.
1.7 Treatment of osteoarthritis
The treatment of OA is diverse, ranging from patient education to surgical intervention,
the main purpose being to prevent further cartilage damage and progression to end-stage
disease that usually is accompanied by debilitating symptoms.
Lifestyle modifications
Many risk factors for OA are amenable to lifestyle changes (Messier et al., 2004). For
instance, weight loss in obese patients reduces the risk of developing OA and improves
symptoms once the disease is established. Also, specific physical therapy, low-impact
aerobic exercises and muscle strengthening improve symptoms in the early stages of OA
(Richmond et al., 2010). The use of a cane or a walker can also be beneficial by reducing
the joint load and providing stability.
Pharmaceutical drugs
Medications currently used to treat patients are unable to reverse the cartilage damage
and are used for treating the symptoms. Paracetamol and non-steroidal anti-inflammatory
drugs (NSAID) are frequently used for symptom control as they provide good pain con-
trol (Richmond et al., 2010; Hochberg et al., 2012). However, there are some concerns
over the long term use of NSAIDs due to the risk of gastrointestinal bleeding and of
cardiovascular events. Glucosamine and chondroitin appear to have anti-inflammatory
and anabolic properties in-vitro (Chan et al., 2005), but the oral administration of these
molecules does not yield clinically relevant effects (McAlindon et al., 2000). Therefore,
its use is not recommended in guidelines published by international bodies (Richmond
et al., 2010; Hochberg et al., 2012; McAlindon et al., 2014).
HA is a GAG found in the synovial fluid and acts as a lubricant. Intra-articular
injection of this molecule has been used as viscosupplementation but no clinically relevant
benefit has been found in terms of pain or function (Rutjes et al., 2012). Intra-articular
steroid injections are useful for short-term relief of pain and inflammation, but do not
prevent cartilage degradation (Richmond et al., 2010).
Surgery
Microfractures, cartilage transplantation and autologous chondrocyte transplantation are
valid treatment options for small, localized, cartilage defects (Van Assche et al., 2010).
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However, the newly formed cartilage does not have the same mechanical properties as
hyaline cartilage (Mollon et al., 2013). Therefore, the relief provided by these treatments
is temporary (Minas et al., 2014).
An arthroscopic debridement of the joint is not recommended as a standard treatment
in OA, except if there are associated intra-articular loose bodies or symptomatic meniscal
lesions (Richmond et al., 2010).
In selected cases, osteotomies are useful in restoring limb alignment and in unloading
areas of damaged cartilage, effectively delaying the symptoms of late stage OA (Maistrelli
et al., 1990; Akizuki et al., 2008).
Partial or total joint arthroplasties, replace the articular surfaces of a joint by metal,
ceramic or polyethylene implants, are a reliable and cost-effective method of treating the
symptoms of late stage OA (Chang et al., 1996). While the longevity of the implants has
improved, with 10-year survival rates reaching as high as 94.8% (94.4-95.2) for cemented
hip implants, there is always the risk of reoperation for septic or aseptic failure of the
implants (Malchau et al., 2002).
1.8 Animal models in osteoarthritis research
Animal models are paramount research tools for studying the pathological processes and
potential therapeutic targets for many diseases, including osteoarthritis as they allow
control of a large number of variables in the disease process, and ideally offer a great
degree of reproducibility.
The ideal animal model for the study of the human OA should be mammalian, in-
expensive, easy to house and manage, with known genome and a wide array of available
molecular tools. In addition, it should have a sufficient size as to make surgical inter-
ventions and collection of synovial fluid feasible; display a consistent and reproducible
disease with a linear progression, occurring in a reasonable time frame; and recapitulate
the human pathology in all tissues of the joint (Little & Smith, 2008). There are several
animal models available but, at the moment, none fulfil all of the above requirements.
Mice (Mus musculus) models of OA have several advantages: they have a small size,
are tractable animals and maintaining them in an animal facility is simpler and more
economical when compared to larger animals such as rabbits, goats, sheep or horses.
The ethical controversies involved are less than those when using cats, dogs or primates.
Finally, their rate of breeding, maturation and disease onset is rapid.
Since the full genome of the mouse is known, it is possible to (i) design strains with
targeted genetic modifications, (ii) design primers for the desired genes and (iii) perform
microarrays or transcriptome studies.
One of their main advantages, is also one of the main drawbacks as their reduced size
limits the discrimination and quantity of tissues, limits the volume of available synovial
fluid and increases the difficulty of surgical procedures; also the joints have a much thinner
articular cartilage compared to larger species making it more difficult to differentiate the
different layers of the hyaline articular cartilage.
The methods of inducing OA are also varied and adequately selecting a method
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is fundamental since it may or may not replicate the sequence of events leading to the
disease in humans. For instance, injection of enzymes or other molecules in the joint may
be a suitable model for inflammatory arthritis but a poor model for primary arthritis;
different methods of induction can yield opposite results even when the same animal
model is used (Little & Zaki, 2012).
In addition to the models where OA has a spontaneous onset secondary to the ageing
process (Mason et al., 2001; Stoop et al., 1999), there are a variety of methods for inducing
OA in mice (Pritzker, 1994; Little & Smith, 2008), such as genetic modification (Ameye
& Young, 2002), intra-articular injection (van der Kraan et al., 1990; van Beuningen
et al., 2000), or surgical intervention (Kamekura et al., 2005; Glasson et al., 2007).
Although there are different surgical methods for inducing OA in the mouse knee,
the underlying concept is to destabilize the joint creating a mechanical overload that
leads to cartilage destruction. To effectively study the pathological process of cartilage
destruction using surgically induced models, a number of factors have to be considered;
(i) a greater degree of instability causes a more severe and more rapidly progressing
disease (Kamekura et al., 2005), hence, if the objective is to study the initial phases of
the disease process it is preferable to choose one of the milder methods, such as medial
meniscectomy or meniscal destabilization (Glasson et al., 2007) (ii) the strain of animal
(Eltawil et al., 2009) (iii) sex (Ma et al., 2007) and (iv) age of the animal (Loeser et al.,
2012) at the time of surgery also influence the disease progression. In order to make
meaningful comparisons between different experiments all of these variables have to be
controlled.
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Chapter 2
Aims of the study
The aims of the study can be described as follows:
1. Compare the morphological and histological features of surgically induced arthropa-
thy between Hfe-KO and WT mice
2. Identify genes differentially expressed between WT and Hfe-KO mice knee joints
following surgical induction of osteoarthritis
3. Evaluate the relationship between the different genotypes of the HFE gene and
musculo-skeletal complications of hemochromatosis in humans
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3.1.1 Animal model, experimental procedure, feeding and housing
This study protocol was approved by the Portuguese National Authority for Animal
Health (DGAV ref. 0421/000/000/2013) and by the Ethics Committee of the University
NOVA in Lisbon (nº 11/2013/CEFCM). Hfe-KO mice in a C57BL/6 background (Levy
et al., 1999) (Hfe-KO) were used as a model for human HH. A colony of these animals,
as well as of wild-type (WT) C57Bl/6 mice used as control, is routinely maintained at
the University of Algarve Animal Facility. Animals were kept in a 12hrs light/dark cycle,
had access to water and food (SDS RM3A, iron content 161 mg/kg) ad-libitum from
weaning up to time of euthanasia and maintained in specific pathogen-free conditions in
individually ventilated cages with 4-6 animals each, according to the Animal Care and
Use Committee protocols.
A total of 56 ten week-old male mice, 28 of each strain, were used and the allocation of
animals, as summarised in Figure 3.1, was the following; twenty animals for histological
grading of cartilage destruction; ten animals for micro-CT and assessment of iron deposits
in the knee joint; twenty animals for assessment of gene expression, of which twelve were
also used for determining iron liver concentration and serum iron parameters; and six
animals were used for immuno-histochemical staining.
Osteoarthritis was induced by medial meniscectomy and medial collateral ligament
transection, as previously described by Kamekura (Kamekura et al., 2005). Briefly, ten
week-old male mice were anaesthetised with a combination of ketamine (1mg/10g body
weight , i.p., Merial France), xylazine (0.1mg/10g body weight, i.p., Bayer, Germany)
and acepromazine (0.03mg/10g body weight, i.p., Vétoquinol, France)(Buitrago et al.,
2008). Using a stereomicroscope (Nikon SMZ1500) and microsurgical instruments a
medial knee arthrotomy was performed and the patella was externally subluxated, the
right knee medial collateral ligament was transected and the medial meniscus removed
(MNX) (Figure 3.2). The left knee was sham-operated (SHAM), i.e., the arthrotomy
and external subluxation of the patella were performed but no ligament transection or
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Figure 3.1: Flowchart describing the allocation of animals in the different experiments
meniscal excision were made. Care was taken to prevent damage or desiccation of the
articular cartilage. The joint was then irrigated with sterile saline, the articular capsule
closed with 8-0 absorbable suture (Vicryl, Ethicon, USA) and the skin was closed with
6-0 non-absorbable sutures (Ethilon, Ethicon, USA).
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Figure 3.2: Surgical induction of osteoarthritis in the mouse knee. A) Knee joint after
exposure of subcutaneous tissue and medial arthrotomy. B) Knee joint following lateral
subluxation of the patella, exposing the anterior horn of the medial meniscus. C) Excision
of the medial meniscus after sectioning the medial collateral ligament and the anterior
tibio-meniscal ligament. D) Medial meniscus after excision. Images taken through the
stereomicroscope with Olympus OM-D E-M5 camera, Carl Zeiss universal digital camera
adapter d30 and Olympus 60mm MACRO.
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All surgical procedures were performed by the author, who is credited by the Por-
tuguese National Authority for Animal Health as competent to perform experiments with
laboratory animals (DGAV ref. 0421/000/000/2013). The procedures were carried out
during the morning and the surgeon was blinded to the strain of the animals. Animals
were euthanized 8 weeks after surgery and bilateral knee joints were collected and pro-
cessed as described in the next sections. There were no surgery-induced mortality nor
adverse effects and all of the operated animals were included in the analysis.
3.1.2 Assessment of iron accumulation
Unless noted otherwise all the reagents used were purchased from Sigma-Aldrich. For
the assessment of iron accumulation in the liver and blood, samples of 6 animals of each
strain were used. Hepatic non-heme iron concentration in µg of iron per mg of wet
liver weight was determined as previously described (Rebouche et al., 2004). Briefly, a
sample of liver was collected, homogenized in a 1:10 dilution (weight/volume), then equal
volumes of the tissue homogenates and protein precipitation solution (1mol L 1 HCl and
10% trichloroacetic acid) were mixed in “boil-proof” tubes and heated to 95ºC for 1h.
After centrifuging for 10min the supernatant was collected and an aliquot was mixed with
an equal volume of chromogen solution (0.508mmol L 1 of ferrozine, 1.5mol L 1 sodium
acetate and 10% L-ascorbic acid). After 30min at room temperature the absorbance
at 562 nm was measured and the concentration calculated using a calibration curve
prepared on the same day from FeCl3 stock solution [1mgmL 1] and diluted to 5, 10,
15, 25 and 50 µgmL 1 of iron. At the time of euthanasia blood was collected by intra-
cardiac puncture, in tubes containing Heparin-Lithium, and sent to an external certified
commercial laboratory (DNAtech, Lisbon, Portugal) for determination of serum iron,
serum ferritin and also serum transferrin saturation.
3.1.3 Grading of osteoarthritic changes
Bilateral knee joints from 10 animals in each group were isolated, cleaned of adher-
ent soft tissues in ice-cold phosphate buffer saline (PBS) and fixed for 24hrs in 4%
paraformaldehyde in PBS pH7.4, followed by decalcification with 0.5mol L 1 ethylene-
dinitrilotetraacetic acid (EDTA) in PBS pH 7.4 for 3 weeks. After dehydration through
graded alcohols and inclusion in paraffin, 5µm sagittal sections were cut from the medial
compartment of the joints, three sections per level with a 150µm interval between levels,
on a rotary microtome (Microm HM340E, Germany) and stained with Safranin-O/Fast
Green/Meyer’s Hematoxylin. Two separate observers, without knowledge of the strain
and intervention, graded the cartilage lesions using the semi-quantitative scoring system
proposed by Glasson et al. (Glasson et al., 2010), also known as the OARSI scoring sys-
tem for murine osteoarthritis. This system is based on the cartilage destruction extent,
graded 0-6 depending on the depth of the lesion and on the percentage of the articular
surface affected. The medial tibial plateau and the medial femoral condyle were graded
separately. The score for each knee was the sum of the scores from each of the three
sections. The final score for each joint was obtained by averaging both observers’ score
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for that joint.
3.1.4 Morphological characterization of the knee joint by micro-CT
Micro-CT was performed on bilateral knee joints of 5 animals in each group with a
Skyscan 1172 X-ray computed microtomograph (Bruker, Belgium) prior to inclusion in
methyl methacrylate (MMA). The samples were wrapped in laboratory film (Parafilm)
and placed inside an empty 1.5ml tube to prevent desiccation. The tubes were fixed on
the sample holder with adhesive plasticine. For the image acquisition the following pa-
rameters were used: X-ray tube potential 70 kVp, X-ray tube current 100µA, 0.5mm Al
filter, rotation step 0.4º, isotropic voxel size 5µm3, integration time 500ms, frame aver-
aging = 6. For reconstruction we used NRecon software (v1.6.9.8, Bruker, Belgium) with
Gaussian smoothing, ring artefact correction and 40% beam hardening correction applied.
Using Dataviewer software (v1.4.4, Bruker, Belgium) orthogonal sagittal projections of
the entire internal compartment of the knee, from the medial border of the internal tibial
plateau to the tibial insertion of the posterior cruciate ligament, were generated and then
exported to CTAn software (v1.13.11.0, Bruker, Belgium) for further analysis. Coronal
sections of the whole joint were also generated to assess the presence of osteophytes. The
proximal epiphysis of the tibia was selected as a region of interest (ROI). To quantify the
characteristics of the subchondral bone (Botter et al., 2006) the epiphysis was further
divided into a cortical part (subchondral bone plate) and a trabecular part, by manually
drawing an irregular anatomic contour adjacent to the endocortical surface at intervals
of 15 sections, and the software calculated the intermediary contours by interpolation.
These parts were analysed separately (Figure 3.3). The greyscale images were segmented,
using the same manually chosen global threshold for all the samples. The following three
dimensional (3D) morphometric parameters were provided by the software and used to
describe the bone of the trabecular compartment: Bone volume fraction (BV/TV, in %)
is the ratio of the segmented bone volume to the total volume of the region of interest;
Connective density (Conn.D, in mm 3) is a measure of the average number of trabec-
ulae per unit of volume; Trabecular thickness (Tb.Th, in µm) is the mean thickness of
trabeculae;. To describe the subchondral bone plate we measured the average thickness
(Sb.plate.Th, in µm).
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Figure 3.3: Process of micro-CT acquisition and analysis. The digitized image a)
is reconstructed and resliced in orthogonal sagittal and coronal projections b), using a
predefined threshold, the grayscale images are binarized and the ROIs are selected c),
in this case the ROIs are the medial tibial subchondral plate (red) and the medial tibial
subchondral trabecula (green), afterwards d) the software generates a 3D model and
calculates the desired parameters.
3.1.5 Histological evaluation of undecalcified samples
Following micro-CT the samples were included in MMA at 4ºC. From these undecalci-
fied samples, 5µm sagittal sections were cut from the medial knee compartment, eight
sections per level with a 50µm interval between levels, on a heavy-duty microtome (Leica
SM2500S, Germany) equipped with 40º wedge angle, profile-D, tungsten carbide knives.
Sections were stained with Perl’s and counterstained with Neutral Red in order to assess
iron deposition. The ROIs for this analysis were the knee joint and the proximal epiph-
ysis of the tibia. The total area of hemosiderin deposits in the synovial membrane was
measured as previously described (Heiland et al., 2010). Measurements were made using
a semi-automatic image analysis software (ImageJ v1.49). Sections were also stained with
aniline blue / Ponceau fuchsin in order to evaluate the articular calcified cartilage. Af-
ter capturing high-magnification images of the samples we used image analysis software
(ImageJ v1.49) to create a high-resolution panorama of the medial tibial plateu of each
section stained with aniline blue/Ponceau fuchsin, and measure the area stained in pink
that corresponds to the hyaline articular cartilage (HAC) and the area stained in light
blue that corresponds to the articular calcified cartilage (ACC). We then determined the
ratio of HAC/ACC area and the average height of the ACC (Figure 3.4.
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Figure 3.4: Measurement of calcified cartilage. Several high magnification micropho-
tographs were stitched with ImageJ plugin TrakEM2, resulting in a high resolution mosaic
encompassing the entire articular surface of the section of the medial tibial compartment.
The image was then converted to grayscale where the differences between ACC, HAC
and subchondral bone are visible and, using ImageJ, the area and height of each layer
was measured.
3.1.6 Evaluation of gene expression
The bilateral knee joints of ten mice from each strain were used for ribonucleic acid (RNA)
isolation. Immediately after euthanasia, both knee joints were immersed in RNALater
at 4ºC and cleaned of soft tissues including ligaments, menisci and synovial membrane,
in order to isolate the tibial and femoral cartilage and subchondral bone of the medial
knee compartment (Figure 3.5).
Figure 3.5: Samples for molecular biology. a) After euthanasia the joints were cleaned of
soft tissues and the epiphysis was separated from the metaphysis at the level of the growth
plate (arrow); b) the epiphysis was further separated in medial and lateral compartments
(dotted box). The medial compartments were used for evaluation of gene expression and
the lateral compartment was discarded. Images taken through the stereomicroscope
with Olympus OM-D E-M5 camera, Carl Zeiss universal digital camera adapter d30 and
Olympus 60mm MACRO.
The samples were then separated into four groups, WT.SHAM, Hfe-KO.SHAM,
WT.MNX, Hfe-KO.MNX according to the strain of the animal (WT or Hfe-KO) and
the knee (MNX or SHAM) from which the sample originated. In order to obtain enough
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messenger RNA (mRNA) to perform the analysis, the samples were pooled, each pool
containing samples from two knees of the same group, adding to a total of 5 pools in each
group. The pooled samples were stored in RNALater at 4ºC for 24hrs. Afterwards the
excess RNALater was removed and samples were stored at -80ºC until further processing.
The tissue pools were homogenized using a Precellys 24 tissue homogenizer and reinforced
tubes with 2.8mm steel beads. RNA was extracted using TRI Reagent according to the
manufacturer’s indications. RNA was purified using the High Pure RNA Isolation Kit
(Roche) and quantified with an Experion RNA analysis system (Bio-Rad). Only sam-
ples with RNA quality indicator (RQI) >7 were used for the reverse transcription (RT)
and subsequent analysis. The RT reaction was carried out using 0.5µg of total RNA per
reaction with the Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Invit-
rogen) according to the manufacturer’s indications. Two negative control reactions were
prepared, one without template and the other without the M-MLV reverse transcriptase.
Using the Primer Premier v5.0 software, primers were designed for the following mouse
genes;
Aggrecan (Acan)
A disintegrin-like and metallopeptidase with thrombospondin type 1 motif, 5 (Adamts5)
Bone morphogenetic protein 6 (Bmp6)
Collagen, type X, alpha 1 (Col10a1)
Collagen, type II, alpha 1 (Col2a1)
Hemochromatosis (Hfe)
Interleukin 1 beta (Il1b)
Interleukin 6 (Il6)
Matrix metallopeptidase 3 (Mmp3)
Matrix metallopeptidase 13 (Mmp13)
Runt related transcription factor 2 (Runx2)
Transferrin receptor (Tfrc)
The corresponding sequences are in Table 3.1. The real-time polymerase chain reac-
tion (RT-PCR) efficiency for each gene was found to have <10% deviation between each
other (Schmittgen & Livak, 2008). Gene relative expression was determined using the 2
-DDCq method (Livak & Schmittgen, 2001). Each RT-PCR was carried out using 50ng
of complementary deoxyribonucleic acid (cDNA), 10µl SsoFast™ EvaGreen® Supermix
(Bio-Rad), 300mmol l 1 of primers in a volume completed to 20µl with high-purity water
free of DNase and RNase. Amplifications were performed in a Bio-Rad CFX-96 machine.
The RT-PCR was carried out for 40 cycles using the parameters specified by the manu-
facturer for the combination of machine and master mix. Each reaction was carried out
in triplicate and the final Cq value of each biological replicate was the average of the
technical triplicates. The ribosomal protein L13A (Rpl13a) gene was used as a control
of endogenous gene expression (Curtis et al., 2010) and the WT.SHAM group as the
reference condition.
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3.1.7 Immunohistochemistry
Bilateral knee joints of three mice from each strain were used for immunohistochem-
ical localization of a disintegrin and metallopeptidase with thrombospondin motifs 5
(ADAMTS5), type X collagen, MMP3 and matrix metallopeptidase 13 (MMP13). The
samples were fixed, decalcified and embedded in paraffin as described above. After de-
waxing and rehydration, epitope retrieval was performed by heating the sections at 80ºC
for 25minutes in Tris-EDTA pH 9 buffer. To increase the permeability of the extracel-
lular matrix, sections were incubated with 2.5% hyaluronidase for 30 min at 37ºC as
previously described (Kamekura et al., 2005). After blocking for 30min at room tem-
perature with Tris buffered saline (TBS) containing 5% goat serum + 1% bovine serum
albumin, the sections were incubated with polyclonal rabbit antibodies against mouse
MMP3, MMP13 (Proteintech, England) , ADAMTS5 (Abcam ab41037) at a dilution
of 1:40 and against type X collagen (Abcam ab58632) at a dilution of 1:20 for 24 h at
4ºC. The sections were then treated with 0.3% hydrogen peroxide in TBS for 15 min to
block endogenous peroxidases, rinsed with TBS + 0.05% Tween-20 and incubated with
horseradish peroxidase-conjugated goat antibodies against rabbit IgG (Sigma-Aldrich) at
a 1:100 dilution for 1 h at room temperature. After rinsing with TBS the sections were
covered with a 0.05% 3,3’-diaminobenzidine solution for 5 min at room temperature to
visualize the location of the target protein-primary-secondary antibodies complex, coun-
terstained for 30s with Mayer’s haematoxylin, left to air-dry and then mounted in DPX
mounting medium.
3.1.8 Statistical analysis
Unless stated otherwise, results are expressed as the mean and corresponding 95% Con-
fidence Interval (CI). The bar and range plots were generated to observe the distribution
of the mean (bar) and corresponding 95% CI (upper and lower range). In the instances
where the sample size in each group is smaller than n=10 scatter plots were generated
instead of the bar plots. The Student’s-t test was used to compare continuous variables
between different strains. The non-parametric Mann-Whitney U test was used to com-
pare differences between ordinal variables or when the assumptions of normality and
homoscedasticity were not met. Pairwise comparisons using paired t-tests with Holm’s
P-value adjustment were used to compare continuous variables between different groups
(WT.SHAM vs. WT.MNX vs. Hfe-KO.MNX vs. Hfe-KO.SHAM), in order to account
for the correlation between joints of the same animal. The Wilcoxon matched pairs test
with Holm’s P-value adjustment was used for ordinal variables or when the assumptions
of parametric tests were not met. A two-tailed P-value <0.05 was considered statistically
significant. All analysis and plotting were conducted using the R v3.1.1 (R Foundation
for Statistical Computing, Vienna, Austria) software with base, stats, plyr, reshape2 and
ggplots2 packages.
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3.2 Paper II
3.2.1 Patient recruitment and evaluation
Patients who were members of the Association Hémochromatose France (AHF) com-
pleted a self-administered questionnaire that has previously been described elsewhere
(Richette et al., 2010). Patients were informed of the purpose of the study and gave
their informed consent. This study was conducted in accordance with the recommen-
dations of the Helsinki Declaration. The Institutional Review Board (n°IRB00006477-
Comitéd’évaluation de l’éthique des projets de recherché biomédicale du CHU Nord-
Hôpital Bichat, Paris) has reviewed and approved this study (n°10-074). We collected
the following data: demographic characteristics (age, sex, weight, height, smoking habit,
menopausal status); details of HH history (HFE genotype, ferritin level and transferrin
saturation at diagnosis, symptoms before diagnosis); general clinical features (asthenia,
diabetes mellitus, cardiac disease); joint and spine involvement (patients were asked if
they had received a diagnosis of OA by a physician; if they had ever complained of low
back pain or sciatica; if they had knee-, hip-, or ankle-replacement prosthesis); bone
involvement (patients were asked if they had received a diagnosis of osteoporosis (OP)
by a physician and if they had a history of fractures). To confirm the validity of the
genotype reported by patients, we reviewed the medical records of a sample of 20 pa-
tients followed in P. Richette’s department and who had reported having homozygosity
(n=10) and duplex heterozygosity (n=10). The rate of concordance was 95% (19 of 20).
One patient who declared homozygosity was actually duplex heterozygous.
3.2.2 Statistical analysis
Continuous variables were tested for normality and homoscedasticity. All continuous
variables in our sample were non-normally distributed (skewed) and were described us-
ing the median and interquartile range (IQR). Differences between groups were assessed
using the Mann-Whitney test. Association between categorical variables was tested using
the chi-squared test. Crude odds ratios (OR) were calculated using a univariate logistic
regression model, with the patient genotype (C282Y/C282Y vs. C282Y/H63D) as the
independent variable and the outcome of interest as the dependent variable. Adjusted
odds ratios (aOR) were calculated using a multiple logistic regression model, with the pa-
tient genotype and clinically relevant confounders (Richette et al., 2010) as independent
variables and the outcome of interest as the dependent variable. The design of our study
precluded the assessment of iron overload by liver biopsy; therefore, we used ferritin level
as a surrogate marker, with severity of iron overload defined by serum ferritin level >1000
µg/L at diagnosis. This cut-off has previously been found to be clinically appropriate
(Allen et al., 2010). All statistical analyses were carried out using Stata 13.1 (StataCorp,
College Station, TX). A 2-tailed p <0.05 was considered statistically significant.




All the animals initially operated were included in the final analysis; the experimental
procedure had no adverse effects on the mice.
Mice not expressing the Hfe allele have increased iron accumulation in the
serum, liver and knee synovial membrane
The Hfe-KO mice had a significant plasmatic iron overload (n=6 per group, Figure 4.3A)
and up to a 5 fold increase in hepatic iron content when compared to their controls [1121,
95% CI (927, 1316) µg iron/mg of wet liver weight vs. 282, 95% CI (196, 367) µg iron/mg
of wet liver weight; P-value =0.002, respectively, n=6 per group].
To evaluate the iron accumulation in the joints of Hfe-KO mice we used undecalcified,
MMA-embedded sections of the knee, stained with Perl’s. We observed hemosiderin
deposits in the synovial membrane of the knee but not in the cartilage (Figure 4.1.
These occupied a significantly greater area in the Hfe-KO mice, although there was no
significant difference between the MNX and the SHAM operated sides (n=5 per group,
Figure 4.3B). Unpublished data from our research team (Simão M) showed that in non-
operated knees of Hfe-KO mice there is no accumulation of hemosiderin in the synovial
membrane at 18 weeks of age (Figure 4.2).
These observations suggest that the hemosiderin deposits originate from the blood
that enters the joint following the arthrotomy. The higher iron content of the Hfe-KO
mice blood could explain the greater hemosiderin accumulation.
Using RNA extracted from the subchondral bone and articular cartilage we examined
the Hfe and Tfrc mRNA expression. RT-PCR analysis confirmed the decreased Hfe
expression in the Hfe-KO mice (n=5 per group, Figure 4.3C). The Tfrc expression was
significantly decreased in the Hfe-KO SHAM-operated knees and was elevated in both
strains on the MNX-operated knees. (n=5 per group, Figure 4.3D).
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Figure 4.1: Iron accumulation in the knee joints of WT and Hfe-KO mice. Section of undecal-
cified , MMA embedded, knee medial compartment, stained by Perl’s method and counterstained
with Neutral Red. Note the absence of hemosiderin deposits (stained in blue) in the cartilage,
but visible on the medullary space (arrowheads). Scale bar 200 µm.
Figure 4.2: Iron accumulation in the knee joint of non-operated Hfe-KO mice. Section of
undecalcified , MMA embedded, knee medial compartment, stained by Perl’s method. Note the
absence of hemosiderin deposits (stained in blue) in the cartilage and synovial tissue, but obvious
in bone and medullary space.
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Figure 4.3: Iron parameters in WT and Hfe-KO mice (A) Bar plots for the different serum
iron parameters. (B) Perl￿s staining of MMA-embedded knee joint, high magnification view of
the knee synovial membrane to observe the hemosiderin deposits (blue) and the quantification of
their area showing a greater accumulation of iron in the synovial membrane of the Hfe-KO mice.
Scale bar 50 µm. (C) Real time PCR, using mRNA isolated from the medial knee compartment
of 18 weeks-old animals, to detect the expression of the Hfe gene in the Hfe-KO and control
animals (n=5 per group). The results confirm that the Hfe gene is not expressed in the bone
and cartilage of the Hfe-KO mice. (D) RT-PCR, using mRNA isolated from the medial knee
compartment of 18 weeks-old animals, to detect the expression of the Tfrc gene. The results show
that in Hfe-KO there is an underexpression of the Tfrc gene and that the medial meniscectomy
leads to an overexpression of this gene. Data are shown as individual values (shapes) with the
corresponding 95% CI (range).
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Hfe-KO mice have increased cartilage degeneration and subchondral bone
volume following the surgical induction of OA
The Hfe-KO mice were morphologically indistinguishable from their WT counterparts
and had similar body weight at the time of euthanasia [24.5, 95% CI (23.4, 25.6)g vs.
25.2, 95% CI (24.3, 26.1) g respectively; P-value=0.33; n=28 per strain]. To evaluate
the effect of the iron overload in the development of OA we surgically induced OA in
Hfe-KO mice and in WT controls, using a previously described technique (Figure 3.2)
(Kamekura et al., 2005). At 8 weeks after the intervention the MNX-operated knees of
the Hfe-KO mice showed a higher level of cartilage destruction (Figure 4.4A), resulting
in significantly higher summed tibial and femoral OOARSI scores for the medial femoral
condyle and medial tibial plateau (n=10 per group, Figure 4.4B).
We assessed the ACC and the HAC of the tibial plateau in the undecalcified, MMA-
embedded knee sections. The MNX operated knees had a significantly lower ACC thick-
ness, lower HAC/ACC ratio and greater subchondral bone height (n=5 per group, Figure
4.5).
To better evaluate the subchondral bone architecture of the medial tibial plateau, we
performed micro-CT scans of the knee joints (Figure 4.6A). The MNX-operated knees
in both strains showed an increase in bone volume, in trabecular thickness and in sub-
chondral plate thickness, these parameters were significantly greater in the Hfe-KO mice
(n=5 per group, Figure 4.6B).
Using RNA extracted from the subchondral bone and articular cartilage, we examined
Bmp6 expression, a signalling molecule involved in iron homeostasis (Andriopoulos et al.,
2009) and bone formation (Kugimiya et al., 2005) and found it to be increased in the
Hfe-KO MNX operated knees compared to their WT controls (n=5 per group, figure
4.6C). These findings suggest that the Hfe-KO animals have an accelerated progression
of the surgically induced OA, when compared to their WT controls.
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Figure 4.4: Cartilage changes following meniscectomy in the knee joints of WT and Hfe-
KO mice (A) Haematoxylin-Fast Green-Safranin-O staining of the medial femoral condyle and
tibial plateu of control (n=10 per group) and Hfe-KO mice (n=10 per group) at 8 weeks after
surgical induction of OA. Scale bar 50 µm. (B) The Osteoarthritis Research Society International
(OARSI) scores for the medial femoral condyle and medial tibial plateu of control and Hfe-KO
mice (SHAM and MNX operated knees) were obtained by summing the score of three sections
from the lateral, middle and medial one-third of the medial knee compartment from each mouse.
Data are shown as the mean (bar) and corresponding 95% CI (range).
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Figure 4.5: Articular cartilage calcification in the knee joints of WT and Hfe-KO mice. (A)
Ponceau Fuchsin- Aniline Blue staining of undecalcified, MMA embedded, sections of the medial
knee compartment of control and Hfe-KO mice (n=5 per group) at 8 weeks after induction of
experimental OA. The arrows show the height of the pink coloured hyaline articular cartilage
(HAC) and of the blue articular calcified cartilage (ACC). The dotted red line is the limit between
the ACC and the subchondral bone. The MNX knees show a reduction of both ACC and HAC
and increased subchondral bone thickness. Scale bar 100 µm. (B) Bar plots representing the
mean height of the ACC and the ratio between HAC area /ACC area in the different groups
(n=5 per group). The MNX surgery leads to a loss of both ACC and HAC, more pronounced
on the Hfe-KO mice. Data are shown as the individual values (shapes) and corresponding 95%
CI (range).
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Figure 4.6: Subchondral bone changes following meniscectomy in WT and Hfe-KO mice (A)
Knee micro-CT sagittal reconstructions at the level of the middle one-third medial tibial plateu
of control (n=5 per group) and Hfe-KO mice (n=5 per group) at 8 weeks after surgical induction
of OA. Scale bar 500 µm (B) Quantification of microarchitecture parameters of the medial tibial
plateu of mice knees (n=5 per group). The results show that the MNX operated knees of the Hfe-
KO animals have a greater degree of subchondral sclerosis when compared to their WT controls.
Data are shown as the individual values (shapes) with the corresponding 95% CI (range) (C)
RT-PCR, using mRNA isolated from the medial knee compartment of 18 weeks-old animals, to
detect the expression of the Bmp6 gene. The results show that MNX surgery leads to an increase
in the expression of the gene but only in Hfe-KO mice is it significant. Data are shown as the
individual values (shapes) with the corresponding 95% CI (range).
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The expression of genes related to extracellular matrix synthesis, chondrocyte
hypertrophy and cartilage degradation are increased in knee joints of the Hfe-
KO mice
To have a better understanding of the accelerated progression of the articular damage in
the Hfe-KO mice, we investigated the expression of genes known to be involved in the
acute inflammatory response and in the development of OA, namely genes coding for
components of the extracellular matrix, chondrocyte hypertrophic markers, factors that
promote bone formation, cartilage-degrading enzymes and cytokines. Although cytokines
Il1b and Il6 showed no significant change in expression at 8-weeks post surgery (Figure
4.7), the remaining genes were up regulated in all MNX-operated knees (n=5 per group,
Figure 4.8). Only Mmp3, a cartilage-degrading enzyme, was significantly up regulated
in the Hfe-KO mice compared with the WT mice 8 weeks after surgery (n=5 per group,
Figure 4.8).
Figure 4.7: Changes in gene expression of pro-inflammatory citokynes following surgical induc-
tion of osteoarthritis. Real time PCR, using mRNA isolated from the medial knee compartment
of animals euthanized 8 weeks after surgery, to detect the expression of Il-1b and Il-6 in the
cartilage and subchondral bone (n=5 per group). There are no significant changes in the expres-
sion of these pro-inflammatory cytokines at 8 weeks after surgery since the acute inflammatory
response has already subsided and the disease process is in a chronic phase. Data are shown as
the individual data points (shapes) with the corresponding 95% CI (range).
In addition, we evaluated the localization of some of the proteins encoded by these
genes using immunohistochemical staining. Eight weeks after surgery both the Hfe-KO
and the WT MNX-operated knees had a similar percentage of articular chondrocytes
positive for type X collagen, ADAMTS-5 and MMP-13, but the Hfe-KO.MNX knees
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Figure 4.8: Changes in gene expression following surgical induction of osteoarthritis. RT-
PCR, using mRNA isolated from the medial knee compartment of animals euthanized 8 weeks
after surgery, to detect the expression of selected target genes (n=5 per group). The results
confirm that MNX surgery induces the expression of genes related with matrix synthesis, matrix
degradation and chondrocyte hypertrophy and that this is more pronounced in the Hfe-KO mice.
Data are shown as the individual values (shapes) with the corresponding 95% CI (range).
displayed stronger staining and a significantly greater percentage of MMP-3-positive
cells when compared to their controls (n=3 per group, Figure 4.9).
44 CHAPTER 4. RESULTS
Figure 4.9: Immunohistochemistry for, a disintegrin and metallopeptidase with throm-
bospondin motifs (ADAMTS-5), type X collagen, matrix metallopeptidase 3 (MMP-3) and ma-
trix metallopeptidase 13 (MMP-13), in the medial tibial plateu at 8 weeks after MNX surgery
in control (WT.MNX) and Hfe-KO (Hfe-KO.MNX) mice. 3,3’-diaminobenzidine (DAB) coun-
terstained with Harris haematoxilin, scale bars=50 µm. The ratio of positive cells per field was
counted under a microscope at 40x magnification using three sections from three mice. The
results show that the levels of MMP-3 enzyme are significantly higher in the Hfe-KO mice knees
following MNX surgery. Data are the individual values (shapes) with the corresponding 95% CI
(range).
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4.2 Paper II
Demographic and clinical characteristics of patients
In total, 306 patients with HH completed the questionnaire. The sample characteristics
are shown in Table 4.1. The median age of the patients was 60 years (interquartile range
(IQR) = 53 to 68 years); 47.4% were females (80% menopausal). Two hundred and sixty-
six patients (87%) were C282Y/C282Y homozygous and 40 (13%) were C282Y/H63D
compound heterozygous. Median serum ferritin concentration at diagnosis was signifi-
cantly higher in patients with C282Y homozygosity [1090 (610 to 2210) µg l 1 vs. 603
(362 to 950) µg l 1, P<0.001] as was median transferrin saturation [80 (66 to 91)% vs.
63 (55 to 72)%, P<0.001]. The proportion of patients with severe iron overload (>1000
µg l 1) was greater among those with C282Y homozygosity (52.4% vs. 20%, P<0.001).
Table 4.1: Characteristics of patients with hereditary hemochromatosis by genotype.
Data shown as the median and IQR or percentage. TS: transferrin saturation.
C282Y/C282Y, n=266 C282Y/H63D, n=40 P value
Age, years 60 (53 to 68) 61 (55 to 67) 0.50
Women, % 48.8 37.5 0.18
Body mass index, kgm 2 24.8 (22.1 to 26.9) 26.2 (23.5 to 30.3) 0.003
Menopausal women, % 80 80 0.80
Current smoker,% 13.2 7.5 0.30
Serum ferritin concentration
at diagnosis, µg l 1
1090 (610 to 2210) 603 (362 to 950) <0.001
Serum transferrin saturation
coefficient, %
80 (66 to 91) 63 (55 to 72) <0.001
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Self-reported symptoms at time of survey
The prevalence of self-reported joint pain at the time of the survey was significantly
higher for patients with C282Y homozygosity (88.4% vs. 77.5%, aOR 2.8, 95% CI1.2 -
6.9). The prevalence of self-reported asthenia, diabetes and cardiac disease did not differ
between genotypes (Table 4.2).
Table 4.2: Prevalence of self-reported symptoms at time of survey by genotype.OR,
odds ratio; aOR, adjusted OR; 95% CI, 95% confidence interval. *Adjusted for age, sex,










Joint pain, % 88.4 77.5 2.2 (0.96-5.1) 2.8 (1.2-6.9) 0.02
Asthenia, % 79.3 82.1 0.82 (0.34-
1.9)
0.8 (0.33-1.9) 0.56
Diabetes, % 9.7 10 0.98 (0.32-
2.9)
1.2 (0.37-3.9) 0.87





OA, joint replacement and spine involvement
The prevalence of OA was higher with C282Y homozygosity than C282Y/H63D com-
pound heterozygosity: 53.4% vs. 32.5% (aOR = 2.4 [95% CI 1.2 – 5.0]; Table 4.3).
This difference was no longer significant on adjustment for ferritin concentration (aOR
= 1.66 [0.79 – 3.5]). The prevalence of hip replacement was higher for homozygotes than
heterozygotes-11.7% vs. 7.5% (aOR = 1.5 [0.41 – 5.1])—but this difference did not reach
statistical significance. The prevalence of self-reported back pain and sciatica did not
differ between the groups: 71.8% vs. 70% and 47.4% vs. 45%, respectively.
Table 4.3: Prevalence of osteoarthritis, joint replacement, back pain and sciatica by
genotype. OR, odds ratio; aOR, adjusted OR; 95% CI, 95% confidence interval. *Ad-










Osteoarthritis, % 53.4 32.5 2.4 (1.2-4.8) 2.4 (1.2-5) 0.02
Knee replacement, % 5.6 5.0 1.1 (0.25-5.1) 1.5 (0.3-7.1) 0.64
Hip replacement, % 11.7 7.5 1.6 (0.47-5.6) 1.5(0.41-5.1) 0.08
Ankle replacement, % 0.75 2.5 0.3 (0.03-3.3) 0.32 (0.03-4) 0.52
Back pain, % 71.8 70 1.1 (0.53-2.3) 1.2 (0.55-2.6) 0.31
Sciatica, % 47.4 45 1.1 (0.56-2.1) 1.3 (0.65-2.6) 0.59
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Osteoporosis and fractures by genotype
In total, 155 patients (50.7%) reported that they had undergone dual-energy X-ray ab-
sorptiometry (DEXA). All the patients who self-reported OP also reported having under-
gone DEXA. The prevalence of OP was greater for C282Y homozygous than compound
heterozygous patients (25.6% vs. 7.5%; aOR = 3.5 [95% CI 1.1–12.1]); Table 4.4). The
effect of genotype on the prevalence of OP was no longer statistically significant on
adjustment for ferritin concentration (aOR = 2.6 [0.74 – 9.3]).
The prevalence of hip, wrist and vertebral fractures did not differ between the groups:
2.6% vs. 2.5%, 13.2% vs. 7.5% and 7.9% vs. 2.5%, respectively.
Table 4.4: Comparison of the prevalence of osteoporosis and associated fractures by
genotype. OR, odds ratio; aOR, adjusted OR; 95% CI, 95% confidence interval. *Ad-










Osteoporosis, % 25.6 7.5 4.3 (1.3-14.2) 3.5 (1.1-12.1) 0.04
Hip fracture, % 2.6 2.5 1.1(0.13-8.8) 0.66 (0.07-
6.3)
0.64
Wrist fracture, % 13.2 7.5 1.9 (0.55-6.4) 2.3 (0.65-8.2) 0.45
Vertebral fracture, % 7.9 2.5 3.3 (0.44-
25.6)
3.3 (0.42-26) 0.15
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Chapter 5
Discussion
Systemic iron overload secondary to hemochromatosis is associated with articular car-
tilage degeneration, and increased prevalence of osteoarthritis (Husar-Memmer et al.,
2014).
In paper I, experimental OA was surgically induced in the knee of a mouse model of
hereditary hemochromatosis. The knee joints were then evaluated to determine articu-
lar cartilage degeneration, subchondral bone changes and gene expression patterns. In
paper II a large cohort of patients with hereditary hemochromatosis was evaluated in
order to determine the effect of HH genotype on patients self-reported musculoskeletal
complications.
5.0.1 Limitations of the study
The study described in paper I has some limitations; in humans, HH-related OA develops
spontaneously in the fourth and fifth decades of life whereas we used young mice (10-
weeks-old) to study the development of surgically induced OA. Therefore this model
may not accurately represent the progression of the human disease. In addition, since
the observed changes in cartilage and subchondral bone were restricted to a single time-
point it is difficult to conclude about the entire sequence of genetic and morphologic
changes leading to OA, but this could be addressed in future studies. The 8-week time
point was selected since both cartilage and subchondral bone changes are already well
defined (Kamekura et al., 2005) and the disease process is in a quiescent phase (Loeser
et al., 2013).
This study addresses the changes in a limited number of target genes, whose selection
was geared towards the main components of the extracellular matrix (Martin et al., 2001),
the main proteolytic enzymes involved in matrix degradation (Reboul et al., 1996; Blom
et al., 2007; Verma & Dalal, 2011), and the main molecules related with chondrocyte
hypertrophy (Zheng et al., 2003). However, it is possible that other genes play a relevant
role in the development of HH-related OA, a possibility that could be addressed in future
studies.
The study described in paper II also has limitations; patients were asked to remember
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symptoms attributed to hemochromatosis, which might have induced recall bias (Pan-
nucci & Wilkins, 2010). Because of the relatively low number of patients with compound
heterozygosity, the number of rare events such as fractures or joint replacement surgery
was low in this group. This might explain the non-significant findings for joint replace-
ment and fracture.
5.0.2 Changes in cartilage and bone in iron overloaded joints
As previously described (Levy et al., 1999), the Hfe-KO mutation of our mouse model, a
deletion of a large portion of the Hfe gene coding sequence generating a null allele, had
no effect on the morphology of the mice, but caused a significant systemic iron overload
with increased iron content observed in the serum and liver of these mice.
Following arthrotomy, the Hfe-KO mice showed an increased deposition of iron in
the form of hemosiderin in the synovial membrane. Synovial iron accumulation can
also be found in human HH patients and in patients with rheumatoid arthritis (RA)
(Kra et al., 1965; Walker et al., 1972; Heiland et al., 2010). It is thought that the iron
arises not from exchange with the labile iron pool but from blood that enters the joint,
either by trauma or by oozing from an inflamed synovial membrane (Muirden & Senator,
1968). Accordingly, we hypothesise that the iron seen in the knee synovial membrane
would originate from blood entering the joint following the arthrotomy. The greater
hemosiderin accumulation in the Hfe-KO mice joints could, therefore, be explained by
the higher iron content of their blood.
On its own, iron accumulation in the synovial membrane does not appear to be enough
to cause cartilage damage in this time period, as shown by the data from Hfe-KO mice
SHAM-operated knees, since their histological, morphological and gene expression char-
acteristics do not show any evidence of OA and are identical to their WT counterparts.
Feeding the mice with an iron-enriched diet in order to obtain an even greater iron
overload or having a longer follow-up period could yield different results.
The precise role of subchondral bone in the initiation and progression of OA is still un-
clear (Radin & Rose, 1986; Oegema et al., 1997; Burr, 2004). A recent review (Li et al.,
2013), proposes that the non-physiologic strain on the joint, secondary to mechanical
overload caused by either joint instability or reduced congruency, causes micro-damage
to the subchondral bone. This could then lead to increased subchondral bone resorption
and a decrease in thickness in the early-stages of OA. The process of subchondral bone
remodelling progresses to subchondral trabecular sclerosis and increased calcified carti-
lage thickness in the late-stage OA. These changes in subchondral bone architecture are
likely to accompany cartilage damage that could, in turn, influence subchondral bone
degradation, resulting in a vicious cycle. In line with this hypothesis, at 8 weeks post-
surgery, the MNX-operated knees showed features of late-stage OA, namely increased
subchondral bone volume and calcified cartilage thickness. These changes were more
pronounced in the joints with more severe articular cartilage damage, a finding which
was also congruent with data previously reported by other authors (Chappard et al.,
2006; Hayami et al., 2006; Botter et al., 2009).
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5.0.3 Genetic expression in iron overloaded joints
As previously reported in the literature, we found that surgically induced mechanical
instability of the knee joint resulted in deregulation of genes related to extracellular
matrix production, matrix degradation and chondrocyte hypertrophy (Appleton et al.,
2007; Loeser et al., 2013; Bateman et al., 2013). These changes were observable in both
WT and Hfe-KO mice meniscectomized knees, but differences were more evident in the
latter group, providing further evidence for the increased propensity to OA in the Hfe-KO
mice.
The up-regulation of Acan and Col2a1 present in the MNX knees of both strains
probably represents an anabolic response to the cartilage damage. Ultimately it fails to
repair the damaged cartilage, since the mechanical overload is sustained and induces an
intense catabolic response as shown by the up-regulation of matrix proteases.
The presence of excess iron in the synovial tissue could account for the accelerated
OA progression in the meniscectomized knees of the Hfe-KO mice since intra- and extra-
cellular overload of iron in the tissue contributes to an increased generation of ROS after
an initial pro-inflamatory signal (Morris et al., 1986; Sullivan, 2004; Brissot et al., 2012),
such as joint trauma or surgical intervention. The ROS can lead to hyper-activation
of MMPs (Gurjar et al., 2001; Zamboni et al., 2005; Mairuae et al., 2011), a family of
enzymes involved in the breakdown of the extracellular matrix, which is a crucial step
in many normal as well as pathological biological processes (Nagase & Woessner, 1999).
Specifically, recent studies show that the overproduction of ROS in the mitochondria of
the chondrocytes leads to an up-regulation of MMP genes (Reed et al., 2014) and to
increased chondrocyte apoptosis (Collins et al., 2015), contributing to articular cartilage
damage.
Consistent with this hypothesis, following the surgical induction of OA, the Hfe-KO
mice displayed an increased expression of the Mmp3 gene and increased levels of the
enzyme, when compared to their WT controls. This enzyme is capable of degrading
several components of the extracellular matrix (Hasty et al., 1990; Wu et al., 1991),
making it less resilient to the mechanical stress and accelerating the progression of OA
(Blom et al., 2007; Bateman et al., 2013). Therefore an increase in Mmp3 expression
could be one of the factors contributing to the greater susceptibility to cartilage damage
observed in the Hfe-KO mice knees.
The increase in Runx2 expression found on MNX-operated knees was related to the
mechanical overload caused by the meniscectomy. Previous studies found that mechanical
overload on the joints leads to induction of the transcription activator Runx2 (Kawaguchi,
2008), increasing the expression of type X collagen (Zheng et al., 2003), which in turn will
lead to chondrocyte hypertrophy, apoptosis and endochondral ossification. In accordance
with previous studies (von der Mark et al., 1992; Eerola et al., 1998), the expression of
type X collagen was altered in the joints presenting OA-related morphological changes
and an increase in type X collagen expression was positively correlated to the severity
of cartilage degeneration. These findings are in agreement with previous data from
Walker et al (Walker et al., 1995), who have shown that expression of type X collagen
was induced in response to the extracellular matrix damage caused by the osteoarthritic
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process. The increased expression of Bmp6 in the MNX-operated joints of Hfe-KO mice
could be secondary to the iron overload, since the BMP6-SMAD signalling pathway is an
important regulator of hepcidin expression (Andriopoulos et al., 2009; Corradini et al.,
2009; Corradini et al., 2011). Bmp6 also has an anabolic role in bone metabolism since it
is expressed in hypertrophic chondrocytes, inducing the formation of endochondral bone
(Kugimiya et al., 2005). This data is coherent with our findings in that the increased
expression of Bmp6 was observed in the knees with greater subchondral bone thickness
and with greater type X collagen expression.
Previous reports show that the levels of proinflammatory cytokines are elevated in
the first days following injury (Irie et al., 2003; Haslauer et al., 2014) and then gradually
decrease in the following weeks, eventually returning to normal levels (Bigoni et al., 2013;
Ward et al., 2008). The absence of significant differences in the expression of Il1b and
Il6 in this study could be explained by the fact that the mice were evaluated at 8 weeks
after the initial injury, when the disease process is already in a quiescent phase (Loeser
et al., 2013).
5.0.4 Role of genotype in musculoskeletal complications
In accordance with previous reports (Pawlotsky et al., 1999; Burke et al., 2000; Walsh
et al., 2006; Saliou et al., 2013) , the HH patients in paper II, with the homozygous
C282Y/C282Y genotype, showed significantly higher ferritin and transferrin saturation
coefficient values, when compared to patients with compound heterozygosity. Interest-
ingly, about half of the homozygous patients showed severe iron overload. BMI was
greater for compound heterozygous than for homozygous patients, similarly to what was
found recently by other workers (Wang et al., 2012; Saliou et al., 2013). Indeed, co-
morbid factors such as alcohol abuse and obesity are more prevalent in C282Y/H63D
than C282Y/C282Y patients (Saliou et al., 2013). The two genotype groups did not
differ in prevalence of self-reported asthenia, cardiac disease or diabetes, findings which
are similar to those reported by Waalen et al. (Waalen et al., 2002), showing that pa-
tients with different genotypes of HFE self-reported similar rates of symptoms commonly
associated with iron overload.
Several studies (Olynyk et al., 1999; Bulaj et al., 2000; von Kempis, 2001; Ross et al.,
2003; Cauza et al., 2005; Carroll, 2006; Alizadeh et al., 2007; Allen et al., 2008; Crooks
et al., 2009; Sahinbegovic et al., 2010b; Zwerina & Dallos, 2010) have documented the
association of HH with an clinically relevant arthropathy that may seriously affect quality
of life (Adams & Speechley, 1996). This arthropathy can be severe, as highlighted by
the high prevalence of hip, knee and ankle joint replacement in these patients (Richette
et al., 2010; Sahinbegovic et al., 2010a; Elmberg et al., 2013).
In our study, prevalence of self-reported OA was greater in patients with C282Y
homozygosity than C282Y/H63D compound heterozygosity, after adjustment for con-
founding variables. The prevalence of hip replacement surgery had a tendency to be
increased, among patients with C282Y homozygosity, when compared to patients with
compound heterozygosity, as reported recently by Wang (Wang et al., 2012). This in-
creased prevalence of OA in C282Y homozygotes might be related to the more severe
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iron overload in these patients.
Indeed, although the role of iron overload in the genesis of HH-related OA is still
not fully understood (Husar-Memmer et al., 2014), it can lead to iron accumulation
in the synovium and cartilage of HH patients, as seen in histological studies (Walker
et al., 1972; Schumacher, 1982), and to increased ferritin concentrations in synovial fluid
(Carroll et al., 2010). Some of this iron may be in the form of non-transferrin–bound
iron (de Valk et al., 2000), and might therefore have deleterious effects (Brissot et al.,
2012) on synovial tissue, promoting inflammation due to neutrophil infiltration (Heiland
et al., 2010) and tissue damage (Pantopoulos et al., 2012), as was demonstrated for the
liver (George et al., 1998). Iron deposits were found in synovial tissue from patients with
inflammatory arthritis (Muirden & Senator, 1968), which suggests a link between iron
content and inflammation. More recently, the serum level of vascular adhesion molecule
1 (VCAM-1) was found associated with radiographic measures of HH arthropathy, which
suggests its involvement in HH joint damage (Nell-Duxneuner et al., 2013).
Patients with HH have shown disc degeneration and calcifications in the intervertebral
discs due to calcium pyrophosphate crystal deposits (Bywaters et al., 1971; Hamilton
et al., 1981). In a retrospective study (Valenti et al., 2008), one third of patients with
HH showed spine arthropathy on X-ray. The literature contains no data on the prevalence
of low back pain in patients with a clinical phenotype of HH. Both our genotype groups
showed similar self-reported prevalence of low back pain and sciatica, which suggests that
the lumbar spine involvement in HH is independent of the genotype.
We found an increased prevalence of OP, along with increased prevalence, (although
not statistically significant), of vertebral fractures in homozygote patients. Again, this
observation could be related to the increased iron overload observed in C282Y homozy-
gotes. Indeed, several reports (Guggenbuhl et al., 2005; Weinberg, 2008) have shown
that HH patients, particularly males, are at increased risk of OP, which might be re-
lated to iron overload (Valenti et al., 2009). The pathophysiology of OP in HH is not
entirely clear. Iron-overloaded mice show increased levels of reactive oxygen species, el-
evated serum TNF-a and Il6, which are known to be associated with the severity of iron
overload (Tsay et al., 2010). HFE-/- mice show impaired bone microarchitecture and
increased osteoclast number (Guggenbuhl et al., 2011a). In vitro, iron disrupts the for-
mation of hydroxyapatite crystals (Guggenbuhl et al., 2008) and inhibits the proliferation
and differentiation of osteoblasts (Messer et al., 2009; Yang et al., 2011). As reported by
the previous studies, animal and in vitro data support the hypothesis that iron in excess
can directly affect bone formation and remodeling (de Vernejoul et al., 1984; Isomura
et al., 2004) contributing to the onset of OP.
5.0.5 Future directions
One interesting question to be addressed in a future study is the pattern of gene expression
in the synovial membrane in the presence of iron overload. The synovial cells produce
inflammatory mediators that lead to cartilage breakdown (Sellam & Berenbaum, 2010)
and also have the ability to produce ROS with tissue damaging potential in the presence
of iron (Morris et al., 1986). Also, a recent study (Lambert et al., 2014) showed that in
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the synovial membrane of patients undergoing joint replacement surgery, there was an
up-regulation of the expression of the BMP6 gene, among others. BMP6 is one of the
key regulators of iron metabolism (Meynard et al., 2009) the up-regulation of this gene
in the synovial membrane of end-stage OA could mean that iron overload also plays a
role in the development of idiopathic OA.
Another interesting follow-up study would be to investigate the effect of the Mmp3-
KO mutation (Li et al., 2004) in the Hfe-KO mice. In addition, it will be important to
know if there are other proteolytic enzymes with a relevant role in cartilage degradation
beside the ones already studied here. A whole transcriptome sequencing approach coupled
to a proteome identification strategy could be of relevance to provide further answers to
this important question.
Alternatively, it would be interesting to perform a microarray study of cartilage and
synovial tissue from HH patients with and without arthropathy. The objective would be
to identify differentially expressed genes in the healthy and diseased joints of patients
with clinical HH. Hopefully these genes could act as makers of OA progression and be
used to identify patients at risk of developing HH-related OA. This information could
also contribute to find possible therapeutic targets for OA, a result that would be very
relevant given the large number of patients worldwide, with a tendency to increase, due
to the expected ageing of the population.
Chapter 6
Conclusions
At 18 weeks, mice with the Hfe-KO phenotype had a systemic iron overload showing
higher iron content in liver, plasma and synovial membrane when compared to their WT
controls.
Meniscectomy caused degradation of articular cartilage, sclerosis of the subchondral
bone and increased expression of genes linked with ECM synthesis, chondrocyte hyper-
trophy and matrix proteases.
The gene expression profile observed in the mice is compatible with a remodelling
response, up-regulation of the anabolic pathway, increasing the formation of ECM in
order to repair the damaged areas. This response is not effective, since the sustained
adverse mechanical environment induces the catabolic pathway, with the production of
matrix-degrading enzymes, resulting in the degradation of the hyaline articular cartilage
and increased chondrocyte hypertrophy.
At the same time, the osteogenic pathway observed in the growth plate is reinstated
and the articular calcified cartilage undergoes ossification leading to an increased thick-
ness of the subchondral bone plate. The trabeculae of the subchondral zone also expe-
rienced an abnormal growth. This abnormally thickened and sclerotic bone is mainly
located in the zones of greater cartilage destruction.
All the changes stated above, particularly the expression of the gene encoding Mmp3,
were more pronounced in the Hfe-KO animals resulting in a more severe phenotype
following the surgical induction of OA.
Although there was a visible hemosiderin accumulation in the SHAM operated joints
of the Hfe-KO mice, it was not enough to cause cartilage degradation or subchondral
bone changes at eight weeks post-surgery.
The findings stated above suggest that systemic iron overload is not a direct cause
of OA, but acts as a susceptibility factor, amplifying the damage caused by mechanical
overload of the joint.
In humans with hereditary hemochromatosis, homozygosity for the C282Y muta-
tion was associated with a more severe iron overload, when compared with compound
heterozygotes C282Y/H63D. The homozygotes also had an increased prevalence of mus-
culoskeletal HH-related complications suggesting a relationship between the systemic iron
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overload and the damage to bone and cartilage.
Our findings in mice could help to explain why HH-related OA does not affect all
patients that have clinical manifestations of HH, and usually is only symptomatic at the
fourth and fifth decades of life. According to our model, not only would the patient have
to develop a clinically relevant iron overload, but also to sustain some form of damage
to their joints, probably in the form of minor traumas that are common in everyday
life. Such traumatic episodes typically cause oozing of blood into the joint. Since HH
patients usually have high blood iron concentrations, the amount of iron entering the
joint and being deposited in the synovial membrane in the form of hemosiderin would
be considerable. After several episodes of minor trauma there might be enough iron
accumulation in the synovial membrane to act as a susceptibility factor, amplifying the
deleterious effect of subtle mechanical overload of the joints, and leading to an accelerated
OA progression in these patients.
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s u m m a r y
Objective: Hereditary hemochromatosis (HH) is a disease caused by mutations in the Hfe gene charac-
terised by systemic iron overload and associated with an increased prevalence of osteoarthritis (OA) but
the role of iron overload in the development of OA is still undefined. To further understand the molecular
mechanisms involved we have used a murine model of HH and studied the progression of experimental
OA under mechanical stress.
Design: OAwas surgically induced in the knee joints of 10-week-old C57BL6 (wild-type) mice and Hfe-KO
mice. OA progression was assessed using histology, micro CT, gene expression and immunohistochem-
istry at 8 weeks after surgery.
Results: Hfe-KO mice showed a systemic iron overload and an increased iron accumulation in the knee
synovial membrane following surgery. The histological OA score was significantly higher in the Hfe-KO
mice at 8 weeks after surgery. Micro CT study of the proximal tibia revealed increased subchondral bone
volume and increased trabecular thickness. Gene expression and immunohistochemical analysis showed
a significant increase in the expression of matrix metallopeptidase 3 (MMP-3) in the joints of Hfe-KO
mice compared with control mice at 8 weeks after surgery.
Conclusions: HH was associated with an accelerated development of OA in mice. Our findings suggest
that synovial iron overload has a definite role in the progression of HH-related OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Introduction
Osteoarthritis (OA) is a disease of the joints characterized by
progressive articular cartilage destruction and subchondral bone
changes. Several factors influence OA development, including ge-
netic background, past joint injuries, mechanical overload and
ageing1,2. The pathologic process that leads to cartilage destruction
involves a disruption of the normal resting state of chondrocytes,
leading to an increased production of both matrix proteins and
matrix degrading enzymes such as matrix metallopeptidase (MMP)
and a disintegrin and metallopeptidase with thrombospondin
motifs (ADAMTS)3.
Hereditary hemochromatosis (HH), a chronic disease caused by
mutations in the Hfe gene4 and characterized by systemic iron
overload that causes damage in the liver, heart and endocrine or-
gans5, is associated with an increased incidence of OA6 and joint
replacement surgery7e9. Although liver and heart complications
are the main causes of mortality in patients with HH, arthropathy
has the greatest impact on the quality of life and rarely benefits
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from therapeutic phlebotomies10. Studies of human joint tissue
have shown hemosiderin accumulation in the cartilage and syno-
vial tissue and histological features reminiscent of OA and of
rheumatoid arthritis (RA)11,12 and increased ferritin levels in the
synovial fluid13 of affected joints, but it is unclear how the iron
overload damages the joints and which HH patients will develop
musculoskeletal complications14.
Previous reports have shown that murine models of HH can be
useful in studying the pathogenesis of HH-related liver disease15,
HH-related diabetes16 and HH-related changes in bone meta-
bolism17, but there are no studies using a murine model of HH to
investigate the effect of iron overload in articular cartilage.
In order to investigate the role of iron overload in the develop-
ment of OAwe induced OA18 in a mouse model of HH19 and studied
the subsequent morphological, histological and genetic changes
occurring in the cartilage and subchondral bone of the knee joint.
Materials and methods
Details of additional data, methods, primers and reagents are
available in the Supplementary information material.
Animal model, experimental procedure, feeding and housing
TheHfe-KOmice in a C57BL/6 background19 (HFE-KO) were used
as a model for human HH. C57Bl/6 mice from the University of
Algarve Animal Facility in-house colony were used as wild-type
controls. Distribution of animals between groups and tasks is
further explained in Supplementary fig. 1. Animals were main-
tained in specific pathogen-free conditions and had access to water
and food ad-libitum fromweaning up to time of euthanasia. OAwas
induced in the right knee joint of 10-week-old Hfe-KO and wild-
type mice by sectioning the medial collateral ligament and
excising of the medial meniscus (MNX) using a microscope18. The
left knee was sham-operated (SHAM). All the animals were
euthanized 8 weeks after surgery and bilateral knee joints were
collected, processed and used as described below. All the pro-
cedures were approved by the Portuguese National Authority for
Animal Health (Ref. 0421/000/000/2013) and by the Animal Facility
of University of Algarve.
Assessment of iron accumulation
For the assessment of iron accumulation in the liver and blood,
samples of six animals of each strain were used. At the time of
euthanasia blood was collected by intra-cardiac puncture for
determination of serum iron, serum ferritin and serum transferrin
saturation; liver tissue was collected to determine the hepatic non-
heme iron concentration20.
Grading of osteoarthritic changes
Bilateral knee joints from ten animals in each group were iso-
lated, cleaned of adherent soft tissues in ice-cold PBS and fixed for
24 hrs in 4% paraformaldehyde in PBS pH 7.4, followed by decal-
cificationwith 0.5 M Ethylenedinitrilotetraacetic acid (EDTA) in PBS
pH 7.4 for 3 weeks. After dehydration through graded alcohols and
inclusion in paraffin, 5 mm sagittal sections were cut from the
medial compartment of the joints and stained with Safranin-O/Fast
Green/Meyer's Hematoxylin. Two separate observers, blinded to
the strain and intervention, graded the cartilage lesions (grade
0e6) using the Osteoarthritis Research Society International
(OARSI) scoring system for murine OA21. The medial tibial plateau
and the medial femoral condyle were graded separately. The final
score for each joint was the average of both observers score.
Morphological characterization of the knee joint by micro-CT
Micro-CT was performed on bilateral knee joints of five animals
in each group with a Skyscan 1172 X-ray computed microtomo-
graph (Bruker, Belgium). For the image acquisition the following
parameters were used: X-ray tube potential 70 kVp, X-ray tube
current 100 mA, 0.5 mm Al filter, rotation step 0.4!, isotropic voxel
size 5 mm3, integration time 500 ms, frame averaging ¼ 6. The
proximal epiphysis of the tibia was selected as region of interest
(ROI). To quantify the characteristics of the subchondral bone22 the
epiphysis was further divided in a cortical part (subchondral bone
plate) and a trabecular part. The following 3D morphometric pa-
rameters were used to describe the bone of the trabecular
compartment: Bone volume fraction (BV/TV, in %) is the ratio of the
segmented bone volume to the total volume of the region of in-
terest; Connective density (Conn.D, in mm#3) is a measure of the
average number of trabeculae per unit of volume; Trabecular
thickness (Tb.Th, in mm) is the mean thickness of trabeculae. To
describe the subchondral bone plate we measured the average
thickness (Sb.Th, in mm).
Histological evaluation of undecalcified samples
Following micro-CT the samples were included in methyl
methacrylate (MMA) at 4!C. From these undecalcified samples,
5 mm sagittal sections were cut from the medial knee compartment
on a heavy-duty microtome equipped with tungsten carbide kni-
ves. Sections were stained with Perl's and counterstained with
Neutral Red in order to assess iron deposition. The regions of in-
terest for this analysis were the knee joint and the proximal
epiphysis of the tibia. The total area of hemosiderin deposits in the
synovial membrane was measured as previously described11.
Evaluation of gene expression
The bilateral knee joints of ten mice from each strain were used
for RNA isolation. Immediately after euthanasia both knee joints
were immersed in RNALater at 4!C and cleaned of soft tissues, in
order to isolate the tibial and femoral cartilage and subchondral
bone of the medial knee compartment. RNA was extracted using
TRI Reagent (SigmaeAldrich), purified using the High Pure RNA
Isolation Kit (Roche) and quantified with an Experion RNA analysis
system (Bio-Rad). The reverse transcription reaction (RT) was car-
ried out using 0.5 mg of total RNA per reaction with the M-MLV
reverse transcriptase (Invitrogen) according to the manufacturer
indications. Real-time PCR was carried out in a Bio-Rad CFX-96
machine, using the parameters specified by the manufacturer for
the combination of machine and master mix. The Rpl13a gene was
used as control of endogenous gene expression23 and the
WT.SHAM group as the reference condition.
Immunohistochemistry
Bilateral knee joints of three mice of each strain were used for
immunohistochemical localization. After dewaxing and rehydra-
tion, epitope retrieval was performed and the sections were incu-
bated with polyclonal rabbit antibodies against mouse MMP-3,
MMP-13 (Proteintech, England), ADAMTS-5 (Abcam ab41037) at a
dilution of 1:40 and against type X collagen (Abcam ab58632) at a
dilution of 1:20 for 24 h at 4!C. The sections were then treated with
0.3% hydrogen peroxide to block endogenous peroxidases, incu-
bated with horseradish peroxidase-conjugated goat antibodies
against rabbit IgG (SigmaeAldrich) at a 1:100 dilution. After
rinsing, the sections were incubated with a 0.05% 3,30-dia-
minobenzidine solution to visualize the location of the target
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protein-primary-secondary antibodies complex and counter-
stained with Mayer's haematoxylin.
Statistical analysis
Unless stated otherwise, results are expressed as the mean and
corresponding 95% Confidence Interval (95% CI). The Student's-t
test was used to compare continuous variables between different
strains. The Mann-Whitney U test was used when comparing
ordinal variables or when the assumptions for a parametric test
were not met. Pairwise comparisons using paired t-tests with
Holm's P-value adjustment were used to compare continuous var-
iables between different groups, in order to account for the corre-
lation between joints of the same animal. The Wilcoxon paired test
with Holm's P-value adjustment was used for ordinal variables. A
two-tailed P-value < 0.05 was considered statistically significant.
All analysis and plotting were conducted using the R v3.1.1 (R
Foundation for Statistical Computing, Vienna, Austria) software.
Results
All the animals initially operated were included in the final
analysis; the experimental procedure had no adverse effects on the
mice.
Mice not expressing the Hfe allele have increased iron accumulation
in the serum, liver and knee synovial membrane
The Hfe-KOmice had a plasmatic iron overload (n¼ 6 per group,
Fig. 1(A)) and up to five fold increase in hepatic iron content when
compared to their controls [1121, 95% CI (927, 1316) mg iron/mg of
wet liver weight vs 282, 95% CI (196, 367) mg iron/mg of wet liver
weight; P-value ¼ 0.002, respectively, n ¼ 6 per group].
To evaluate the iron accumulation in the joints of Hfe-KO mice
we used undecalcified, MMA-embedded sections of the knee,
stained with Perl's. We observed hemosiderin deposits in the sy-
novial membrane of the knee but not in the cartilage
(Supplementary fig. 2). These occupied a greater area in the Hfe-KO
mice, although there was no significant difference between the
MNX and the SHAM operated sides (n ¼ 5 per group, Fig. 1(B)).
Unpublished data from our research team (Sim~ao M) showed that
in non-operated knees of Hfe-KO mice there is no accumulation of
hemosiderin in the synovial membrane at 18 weeks of age
(Supplementary fig. 3). These observations suggest that the he-
mosiderin deposits originate from the blood that enters the joint
following the arthrotomy. The higher iron content of the Hfe-KO
mice blood could explain the greater hemosiderin accumulation.
Using RNA extracted from the subchondral bone and articular
cartilagewe examined theHfe and TfrcmRNA expression. Real-time
PCR analysis confirmed the decreased Hfe expression in the Hfe-KO
Fig. 1. Iron parameters in WT and Hfe-KO mice (A) Bar plots for the different serum iron parameters. (B) Perl's staining of MMA-embedded knee joint, high magnification view of
the knee synovial membrane to observe the hemosiderin deposits (blue) and the quantification of their area showing a greater accumulation of iron in the synovial membrane of
the Hfe-KO mice. Scale bar 50 mm. (C) Real time PCR, using mRNA isolated from the medial knee compartment of 18 weeks-old animals, to detect the expression of the Hfe gene in
the Hfe-KO and control animals (n ¼ 5 per group). The results confirm that the Hfe gene is not expressed in the bone and cartilage of the Hfe-KO mice. (D) Real time PCR, using
mRNA isolated from the medial knee compartment of 18 weeks-old animals, to detect the expression of the Tfrc gene. The results show that in Hfe-KO there is an underexpression of
the Tfrc gene and that the medial meniscectomy leads to an overexpression of this gene. Data are shown as the individual values (shapes) with the corresponding 95% CI (range).
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mice (n ¼ 5 per group, Fig. 1(C)). The Tfrc expression was decreased
in the Hfe-KO SHAM-operated knees and was elevated in both
strains on the MNX-operated knees. (n ¼ 5 per group, Fig. 1(D)).
Hfe-KO mice have increased cartilage degeneration and subchondral
bone volume following the surgical induction of OA
The Hfe-KO mice were morphologically indistinguishable from
their WT counterparts and had similar body weight at the time of
euthanasia [24.5, 95% CI (23.4, 25.6) g vs 25.2, 95% CI (24.3, 26.1) g
respectively; P-value ¼ 0.33; n ¼ 28 per strain].
To evaluate the effect of the iron overload in the development of
OA we surgically induced OA in Hfe-KO mice and in WT controls,
using a previously described technique18. At 8 weeks after the
intervention theMNX-operated knees of the Hfe-KOmice showed a
higher level of cartilage destruction [Fig. 2(A)], resulting in a higher
summed tibial and femoral OARSI scores for the medial femoral
condyle and medial tibial plateau (n ¼ 10 per group, Fig. 2(B)). We
assessed the articular calcified cartilage (ACC) and the hyaline
articular cartilage (HAC) of the tibial plateau in the undecalcified,
MMA-embedded knee sections. The MNX operated knees had a
lower ACC thickness, lower HAC/ACC ratio and greater subchondral
bone height (n ¼ 5 per group, Supplementary fig. 4).
To better evaluate the subchondral bone architecture of the
medial tibial plateau, we performed micro-CT scans of the knee
joints [Fig. 3(A)]. The MNX-operated knees in both strains showed
an increase in bone volume, in trabecular thickness and in sub-
chondral plate thickness, but these increases were greater in the
Hfe-KO mice (n ¼ 5 per group, Fig. 3(B)).
Using RNA extracted from the subchondral bone and articular
cartilage we examined Bmp6 mRNA expression, a signalling mole-
cule involved in iron homeostasis24 and bone formation25 and
found it to be increased in the Hfe-KO MNX operated knees
compared to their WT controls (n ¼ 5 per group, Fig. 3(C)). These
findings suggest that the Hfe-KO animals have an accelerated
progression of the experimental OA, when compared to their WT
controls.
The expression of a gene related to cartilage degradation is
increased in knee joints of the Hfe-KO mice
To have a better understanding of the accelerated progression of
the articular damage in the Hfe-KO mice, we investigated the
expression of genes known to be involved in the acute inflamma-
tory response and in the development of OA, namely genes coding
for components of the extracellular matrix, chondrocyte hyper-
trophic markers, factors that promote bone formation, cartilage-
degrading enzymes and pro-inflammatory cytokines.
Although cytokines Il1b and Il6 showed no meaningful change
in expression at 8-weeks post surgery (Supplementary fig. 5), the
remaining genes were up regulated in all MNX-operated knees
(n¼ 5 per group, Fig. 4). OnlyMmp3, a cartilage-degrading enzyme,
was up regulated in the Hfe-KO, MNX operated knees when
compared with their WT.MNX controls, at 8 weeks after surgery
(n ¼ 5 per group, Fig. 4).
In addition, we evaluated the localization of some of the pro-
teins encoded by these genes using immunohistochemical staining.
Eight weeks after surgery both the Hfe-KO and the WT MNX
Fig. 2. Cartilage changes following meniscectomy in WT and Hfe-KO mice (A) Haematoxylin-Fast Green-Safranin-O staining of the medial femoral condyle and tibial plateau of
control (n ¼ 10 per group) and Hfe-KO mice (n ¼ 10 per group) at 8 weeks after surgical induction of OA. Scale bar 50 mm. (B) The Osteoarthritis Research Society International
(OARSI) scores for the medial femoral condyle and medial tibial plateau of control and Hfe-KO mice (SHAM and MNX operated knees) were obtained by summing the score of three
sections from the lateral, middle and medial one-third of the medial knee compartment from each mouse. Data are shown as the mean (bar) and corresponding 95% CI (range).
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operated knees had a similar percentage of articular chondrocytes
positive for type X collagen, ADAMTS-5 and MMP-13, but the Hfe-
KO, MNX operated knees displayed stronger staining and a greater
percentage of MMP-3 positive cells when compared to their WT
controls (n ¼ 3 per group, Fig. 5).
Discussion
This is the first study describing the effect of systemic iron
overload in the development of OA in vivo, by analysing Hfe-KO
mice. At eight weeks after surgical induction of OA, the Hfe-KO
mice showed an accelerated OA progression associated to a
greater cartilage destruction, greater subchondral bone volume and
an increased expression of a gene related to cartilage degradation
when compared to their wild-type controls.
As previously described19, the mutation had no effect on the
morphology of the mice but caused a significant systemic iron
overload with increased iron content observed in the serum and
liver of the Hfe-KO mice. Following arthrotomy the Hfe-KO mice
showed an increased deposition of iron in the form of hemosiderin
in the synovial membrane. Synovial iron accumulation can also be
found in human HH patients and in patients with RA11. It is thought
that the iron arises not from the exchange with the labile iron pool
but from blood that enters the joint, either by trauma or by oozing
from an inflamed synovial membrane26. Accordingly, we hypothe-
sise that the iron seen in the knee synovial membrane would orig-
inate from blood entering the joint following the arthrotomy. The
greater hemosiderin accumulation in the Hfe-KO mice joints could
be therefore explained by the higher iron content of their blood.
By itself, iron accumulation in the synovial membrane does not
appear to be enough to cause cartilage damage in this time period,
as shown by the data from Hfe-KO mice SHAM-operated knees,
since their histological, morphological and gene expression char-
acteristics do not show any evidence of OA and are identical to their
WT counterparts. Feeding the mice with an iron-enriched diet in
order to obtain an even greater iron overload or having a longer
follow-up period could yield different results.
Previous reports show that the levels of proinflammatory cy-
tokines are elevated in the first days following injury27,28 and then
gradually decrease in the following weeks, eventually returning to
normal levels29,30. This could explain the absence of significant
differences in the expression of Il1b and Il6 in this study since the
Fig. 3. Subchondral bone changes following meniscectomy in WT and Hfe-KO mice (A) Knee micro-CT sagittal reconstructions at the level of the middle one-third medial tibial
plateau of control (n ¼ 5 per group) and Hfe-KO mice (n ¼ 5 per group) at 8 weeks after surgical induction of OA. Scale bar 500 mm (B) Quantification of microarchitecture pa-
rameters of the medial tibial plateau of mice knees (n ¼ 5 per group). The results show that the MNX operated knees of the Hfe-KO animals have a greater degree of subchondral
sclerosis when compared to their WT controls. Data are shown as the individual values (shapes) with the corresponding 95% CI (range) (C) Real time PCR, using mRNA isolated from
the medial knee compartment of 18 weeks-old animals, to detect the expression of the Bmp6 gene. The results show that MNX surgery leads to an increase in the expression of the
gene but only in Hfe-KO mice is it significant. Data are the individual values (shapes) with the corresponding 95% CI (range).
A. Camacho et al. / Osteoarthritis and Cartilage xxx (2015) 1e9 5
Please cite this article in press as: Camacho A, et al., Iron overload in a murine model of hereditary hemochromatosis is associated with
accelerated progression of osteoarthritis under mechanical stress, Osteoarthritis and Cartilage (2015), http://dx.doi.org/10.1016/
j.joca.2015.09.007
mice were evaluated at 8 weeks after the initial injury, when the
disease process is already in a quiescent phase31.
As previously reported in the literature, we found that surgically
induced mechanical instability of the knee joint resulted in
deregulation of genes related to extracellular matrix production,
matrix degradation and chondrocyte hypertrophy31e33, as well as
cartilage degeneration34,35 and subchondral bone sclerosis36,37. All
of these were observable in both WT and Hfe-KO mice meniscec-
tomized knees but differences were more evident in the latter
(Figs. 1e4) providing further evidence for the increased suscepti-
bility for OA in the Hfe-KOmice. On the other hand, the presence of
excess iron in the synovial tissue could also account for the accel-
erated OA progression in the meniscectomized knees of the Hfe-KO
mice since intra- and extra-cellular overload of iron in the tissue
induces the generation of free radicals and reactive oxygen species
(ROS)38e40. These can lead to hyper-activation of MMPs41, a crucial
step in many normal and pathological biological processes42. We
observed that, following the surgical induction of OA, the Hfe-KO
mice displayed an increased expression of MMP-3 when
compared to their WT controls. MMP-3 is an enzyme capable of
degrading several components of the extracellular matrix, making
it less resilient to the mechanical stress and accelerating the pro-
gression of OA33,43. Therefore we hypothesise that the increased
iron content in the synovial membrane contributes to an increased
generation of ROS after an initial pro-inflammatory signal, such as
joint trauma or surgical intervention, causing an up-regulation of
MMP-3 expression, contributing to the greater cartilage damage
observed in the Hfe-KO mice knees.
The precise role of subchondral bone in the initiation and pro-
gression of OA is still unclear44,45. A recent review46 proposes that
the non-physiologic strain on the joint causes micro damage to the
subchondral bone leading to increased resorption and a decrease in
thickness in the early-stages of OA, progressing to subchondral
trabecular sclerosis and increased calcified cartilage thickness in
the late-stage OA. These changes in subchondral bone architecture
are likely to accompany cartilage damage that could, in turn, in-
fluence subchondral bone degradation, resulting in a vicious cycle.
Accordingly, in our study we observed a greater increase in sub-
chondral bone volume and calcified cartilage thickness in the joints
with more pronounced cartilage damage, which was in agreement
to data previously reported by Chappard et al.47, Hayami et al.48 and
Botter et al36.
The present study has some limitations. In humans, HH-related
OA develops in the fourth and fifth decades of life whereas we used
young mice (10-week-old) to study the development of OA there-
fore this model may not accurately represent the evolution of the
human disease. The observed changes in cartilage and subchondral
bone were restricted to a single time-point making it difficult to
conclude about the entire sequence of changes leading to OA, but
this could be addressed in future studies. The time point was
chosen since the cartilage and subchondral bone changes are
already well defined18 and the disease process is in a quiescent
phase31. Our selection of target genes was geared towards the main
components of the extracellular matrix49, the main proteolytic
enzymes involved in matrix degradation43,50 and the main mole-
cules related with chondrocyte hypertrophy51. It is possible that
Fig. 4. Changes in gene expression following surgical induction of OA. Real time PCR, using mRNA isolated from the medial knee compartment of animals euthanized 8 weeks after
surgery, to detect the expression of selected target genes (n ¼ 5 per group). The results confirm that MNX surgery induces the expression of genes related with matrix degradation
and chondrocyte hypertrophy and that this is more pronounced in the Hfe-KO mice. Data are shown as the individual values (shapes) with the corresponding 95% CI (range).
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other genes may also be relevant in the development of HH-related
OA, this could also be addressed in future studies.
In conclusion, we found that HFE-KO mice are an interesting
model for the study of HH-related OA since they developed accel-
erated knee OA progression after medial meniscectomy when
compared to their WT controls, this could be secondary to the
increased expression of MMP-3 observed in the iron-overloaded
joints. Further studies regarding the pathway responsible for
MMPs overexpression in iron-overloaded joints could provide a
better insight into OA pathophysiology and lead to novel thera-
peutic targets.
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Arthropathy that mimics osteoarthritis (OA) and osteoporosis (OP) is considered a compli-
cation of hereditary hemochromatosis (HH). We have limited data comparing OA and OP
prevalence among HH patients with different hemochromatosis type 1 (HFE) genotypes.
We investigated the prevalence of OA and OP in patients with HH by C282Y homozygosity
and compound heterozygosity (C282Y/H63D) genotype.
Methods
A total of 306 patients with HH completed a questionnaire. Clinical and demographic char-
acteristics and presence of OA, OP and related complications were compared by genotype,
adjusting for age, sex, body mass index (BMI), current smoking and menopausal status.
Results
In total, 266 of the 306 patients (87%) were homozygous for C282Y, and 40 (13%) were
compound heterozygous. The 2 groups did not differ by median age [60 (interquartile range
[IQR] 53 to 68) vs. 61 (55 to 67) years, P=0.8], sex (female: 48.8% vs. 37.5%, P=0.18) or
current smoking habits (12.4% vs. 10%, P=0.3). As compared with compound heterozy-
gous patients, C282Y homozygous patients had higher median serum ferritin concentration
at diagnosis [1090 (IQR 610 to 2210) vs. 603 (362 to 950) µg/L, P<0.001], higher median
transferrin saturation [80% (IQR 66 to 91%) vs. 63% (55 to 72%), P<0.001]) and lower me-
dian BMI [24.8 (22.1 to 26.9) vs. 26.2 (23.5 to 30.3) kg/m2, P<0.003]. The overall preva-
lence of self-reported OA was significantly higher with C282Y homozygosity than
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compound heterozygosity (53.4% vs. 32.5%; adjusted odds ratio [aOR] 2.4 [95% confi-
dence interval 1.2–5.0]), as was self-reported OP (25.6% vs. 7.5%; aOR 3.5 [1.1–12.1]).
Conclusion
Patients with C282Y homozygosity may be at increased risk of musculoskeletal complica-
tions of HH.
Introduction
Hereditary hemochromatosis (HH) is an autosomal recessive disorder characterized by in-
creased absorption of dietary iron and rapid iron release from macrophages, which leads to ab-
normal accumulation of iron in several organs, particularly the liver, joints and bones [1, 2]. In
patients with iron overload, 2 hemochromatosis type 1 (HFE) genotypes have been commonly
described: C282Y homozygosity and C282Y/H63D compound heterozygosity. Among patients
of northern European descent, the most common genotype is C282Y homozygosity, account-
ing for about 80% to 90% of HH cases [2].
The musculoskeletal complications of HH have been mainly described in C282Y homozy-
gous patients. These complications consist of an arthropathy that mimics osteoarthritis (OA)
and osteoporosis (OP) [3, 4]. The prevalence of OA ranges from 20% to 80% in homozygous
patients with HH [4]. In addition, such patients are at increased risk of joint replacement [5].
The reported prevalence of OP in these patients ranges from 25% to 35% and OP seems to be
associated with severity of iron overload [1].
Recently, there has been renewed interest in the role of HFE compound heterozygosity
(C282Y/H63D) in the development of HH. Patients with the C282Y/H63D genotype show
iron overload but to a lesser extent than in homozygotes, particularly in the absence of co-
morbid factors [6, 7]. Little is known about the risk of hemochromatosis-related musculoskele-
tal complications with HFE compound heterozygosity.
We aimed to compare the prevalence of HH-related OA and OP in patients with C282Y ho-
mozygosity and those with compound heterozygosity (C282Y/H63D).
Patients and Methods
Patients with HH
Patients who were members of the Association Hémochromatose France (AHF) completed a
self-administered questionnaire that was previously described [8]. Patients were informed of the
purpose of the study and gave their informed consent to be in the study. This study was con-
ducted in accordance with the recommendations of the Helsinki Declaration. The Institutional
Review Board (IRB00006477- Comité d’évaluation de l’éthique des projets de recherche biomé-
dicale du GHU Nord-Hôpital Bichat, Paris) reviewed and approved the study (no. 10–074).
We collected the following data: demographic characteristics (age, sex, weight, height, cur-
rent smoking habit, menopausal status); details of HH history (HFE genotype, ferritin concen-
tration and transferrin saturation at diagnosis, symptoms before diagnosis); general clinical
features (asthenia, diabetes mellitus, heart disease); joint and spine involvement (patients were
asked if they had received a diagnosis of OA by a physician; if they had ever complained of low
back pain or sciatica; if they had knee-, hip-, or ankle-replacement prosthesis); and bone in-
volvement (patients were asked if they had received a diagnosis of OP by a physician; if they
C282Y Genotype and Musculoskeletal Complications in Hemochromatosis
PLOS ONE | DOI:10.1371/journal.pone.0122817 March 30, 2015 2 / 8
had a history of fractures). To confirm the validity of the genotype reported by patients, we
reviewed the medical records of a sample of 20 patients followed in our department who had
reported having homozygosity (n = 10) and duplex heterozygosity (n = 10). The rate of
concordance was 95% (19 of 20). One patient who declared homozygosity was actually
compound heterozygous.
Statistical analysis
Continuous variables were tested for normality and homoscedasticity. Some continuous vari-
ables were non-normally distributed (skewed). Therefore, variables were described with the
median and interquartile range (IQR). Differences between groups were assessed by the Mann-
Whitney test. The association between categorical variables was tested by chi-square test.
Crude odds ratios (ORs) were calculated by an univariate logistic regression model, with the
patient genotype (C282Y/C282Y vs. C282Y/H63D) as the independent variable and the out-
come of interest as the dependent variable. Adjusted ORs (aORs) were calculated by a multiple
logistic regression model, with the patient genotype and clinically relevant confounders as in-
dependent variables and the outcome of interest as the dependent variable. The design of the
study precluded the assessment of iron overload by liver biopsy, so we used ferritin concentra-
tion as a surrogate marker, with severity of iron overload defined by serum ferritin concentra-
tion!1000 μg/L at diagnosis. This cut-off was previously found clinically appropriate [9].
All statistical analyses involved use of Stata 13.1 (StataCorp, College Station, TX). A 2-tailed
p<0.05 was considered statistically significant.
Results
Demographic and clinical characteristics of patients
In total, 306 patients with HH completed the questionnaire. The sample characteristics are
shown in Table 1. The median age of patients was 60 years (IRQ 53 to 68 years); 47.4% were fe-
males (80% menopausal). Overall, 266 patients (87%) were C282Y/C282Y homozygous and 40
(13%) were C282Y/H63D compound heterozygous. Median serum ferritin concentration at di-
agnosis was significantly higher with C282Y homozygosity than compound heterozygosity
[1090 (IQR 610 to 2210) vs. 603 (362 to 950) μg/L, P<0.001], as was median transferrin satura-
tion [80% (IQR 66 to 91%) vs. 63% (55 to 72%), P<0.001]. The proportion of patients with se-
vere iron overload (> 1000 μg/L) was greater with C282Y homozygosity than C282Y/H63D
compound heterozygosity (52.4% vs. 20%, P< 0.001).
Table 1. Characteristics of patients with hereditary hemochromatosis by genotype.
C282Y/C282Y n = 266 C282Y/H63D n = 40 P value
Age, years 60 (53–68) 61 (55–67) 0.50
Women, % 48.8 37.5 0.18
Body mass index, kg/m2 24.8 (22.1–26.9) 26.2 (23.5–30.3) 0.003
Menopausal women, % 77.6 80 0.80
Current smoker, % 13.2 7.5 0.30
Serum ferritin concentration at diagnosis, μg/L 1090 (610–2210) 603 (362–950) < 0.001
Transferrin saturation, % 80 (66–91) 63 (55–72) < 0.001
Data are median (interquartile range) or percentage. NS: not significant
doi:10.1371/journal.pone.0122817.t001
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Self-reported symptoms at the time of the survey
The prevalence of self-reported joint pain at the time of the survey was significantly higher
with C282Y homozygosity than C282Y/H63D compound heterozygosity (88.4% vs. 77.5%,
aOR = 2.8 [95% confidence interval (95% CI) 1.2–6.9]; Table 2). The prevalence of self-reported
asthenia, diabetes and cardiac disease did not differ between the genotypes.
OA, joint replacement and spine involvement
The prevalence of OA was higher with C282Y homozygosity than C282Y/H63D compound
heterozygosity: 53.4% vs. 32.5% (aOR = 2.4 [95% CI 1.2–5.0]; Table 3). This difference was no
longer significant on adjustment for ferritin concentration (aOR = 1.66 [0.79–3.5]). The preva-
lence of hip replacement was higher for homozygotes than heterozygotes–11.7% vs. 7.5%
(aOR = 1.5 [0.41–5.1])—but this difference did not reach statistical significance. The preva-
lence of self-reported back pain and sciatica did not differ between the groups: 71.8% vs. 70%
and 47.4% vs. 45%, respectively.
OP and fractures
In total, 155 patients (50.7%) reported than they had undergone dual-energy X-ray absorpti-
ometry (DEXA). All the patients who self-reported OP also reported having undergone DEXA.
The prevalence of OP was greater for C282Y homozygous than compound heterozygous pa-
tients (25.6% vs. 7.5%; aOR = 3.5 [95% CI 1.1–12.1]); Table 4). The effect of genotype on the
prevalence of OP was no longer statistically significant on adjustment for ferritin concentration
(aOR = 2.6 [0.74–9.3]). The prevalence of hip, wrist and vertebral fractures did not differ be-
tween the groups: 2.6% vs. 2.5%, 13.2% vs. 7.5% and 7.9% vs. 2.5%, respectively.
Table 2. Prevalence of self-reported symptoms at the time of the survey by genotype.
C282Y/C282Y n = 266 C282Y/H63D n = 40 Crude OR (95% CI) aOR*(95% CI) P value
Joint pain, % 88.4 77.5 2.2 (0.96–5.1) 2.8 (1.2–6.9) 0.02
Asthenia, % 79.3 82.1 0.82 (0.34–1.9) 0.8 (0.33–1.9) 0.56
Diabetes, % 9.7 10 0.98 (0.32–2.9) 1.2 (0.37–3.9) 0.87
Cardiac disease, % 15.4 17.5 0.86 (0.36–2.1) 0.98 (0.39–2.5) 0.83
OR, odds ratio; aOR, adjusted OR; 95% CI, 95% confidence interval.
*Adjusted for age, sex, body mass index and current smoking habits.
doi:10.1371/journal.pone.0122817.t002
Table 3. Prevalence of osteoarthritis, joint replacement, back pain and sciatica by genotype.
C282Y/C282Y n = 266 C282Y/H63D n = 40 Crude OR(95% CI) aOR*(95% CI) P value
Osteoarthritis, % 53.4 32.5 2.4 (1.2–4.8) 2.4 (1.2–5) 0.02
Knee replacement, % 5.6 5.0 1.1 (0.25–5.1) 1.5 (0.3–7.1) 0.64
Hip replacement, % 11.7 7.5 1.6 (0.47–5.6) 1.5 (0.41–5.1) 0.08
Ankle replacement, % 0.75 2.5 0.3 (0.03–3.3) 0.32 (0.025–4) 0.52
Back pain, % 71.8 70 1.1 (0.53–2.3) 1.2 (0.55–2.6) 0.31
Sciatica, % 47.4 45 1.1 (0.56–2.1) 1.3 (0.65–2.6) 0.59
* Adjusted for age, sex and body mass index.
doi:10.1371/journal.pone.0122817.t003
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Discussion
We investigated the prevalence of OA and OP, HH-related musculoskeletal complications, by
C282Y homozygosity and compound heterozygosity (C282Y/H63D) genotype and found the
prevalence of both self-reported OA and OP higher for patients with C282Y homozygosity
than compound heterozygosity.
Our study population consisted of 306 patients, the C282Y/C282Y genotype being 6.7 times
more frequent than the C282Y/H63D genotype, which agrees with previous studies of patients
with HH-related musculoskeletal complications [10, 11]. As expected, as compared with pa-
tients with compound heterozygosity, those with the homozygous C282Y/C282Y genotype
showed significantly higher ferritin concentration and transferrin saturation values, and about
half of the homozygous patients showed severe iron overload. BMI was greater for compound
heterozygous than homozygous patients, as was found recently [6]. Indeed, co-morbid factors
such as alcohol abuse and overweight are more prevalent in C282Y/H63D than C282Y/C282Y
patients [6].
In HH, abnormally increased iron absorption leads to iron loading of parenchymal cells in
the liver, pancreas, heart and joints, with subsequent damage to structure and impaired func-
tion [2]. The reasons for the high frequency of the musculoskeletal system involvement in HH
are unknown [2].
In this study, the 2 genotype groups did not differ in prevalence of self-reported asthenia,
cardiac disease or diabetes, which is similar to findings by Waalen et al. [12], showing that pa-
tients with different genotypes of HFE self-reported similar rates of symptoms commonly asso-
ciated with iron overload.
Several studies have well documented the association of HH and an arthropathy that may
seriously affect quality of life [1, 8, 13]. This arthropathy can be severe, as highlighted by the
high prevalence of hip, knee and ankle joint replacement in these patients [5, 8, 10].
In our study, the prevalence of self-reported OA was greater in patients with C282Y homo-
zygosity than C282Y/H63D compound heterozygosity, after adjustment for confounding vari-
ables. The prevalence of hip replacement surgery was greater but not significantly for C282Y
homozygous than compound heterozygous patients, as was found recently [14]. This increased
prevalence of OA in C282Y homozygotes might be related to the more severe iron overload in
these patients. Indeed, this difference was no longer significant after adjustment for ferritin
concentration. Although the role of iron overload in the genesis of HH-related OA is still not
fully understood, iron overload can lead to iron accumulation in the synovium and cartilage of
HH patients, as seen on histology [1], and to increased ferritin concentration in synovial fluid
[15]. Some of this iron can be in the form of non-transferrin–bound iron and might have dele-
terious effects [16] on synovial tissue, promoting inflammation with neutrophil infiltration
[17] and tissue damage, as was demonstrated in the liver [18]. Iron deposits were found in sy-
novial tissue from patients with inflammatory arthritis [1], which suggests a link between iron
Table 4. Prevalence of osteoporosis and associated fractures by genotype
C282Y/C282Y n = 266 C282Y/H63D n = 40 Crude OR(95% CI) aOR*(95% CI) P value
Osteoporosis, % 25.6 7.5 4.3 (1.3–14.2) 3.5 (1.1–12.1) 0.04
Hip fracture, % 2.6 2.5 1.1(0.13–8.8) 0.66 (0.07–6.3) 0.64
Wrist fracture, % 13.2 7.5 1.9 (0.55–6.4) 2.3 (0.65–8.2) 0.45
Vertebral fracture, % 7.9 2.5 3.3 (0.44–25.6) 3.3 (0.42–26) 0.15
* Adjusted for age, sex, body mass index, menopausal status and smoking habits
doi:10.1371/journal.pone.0122817.t004
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content and inflammation. More recently, the serum level of vascular adhesion molecule 1 was
found associated with radiographic measures of HH arthropathy, which suggests its involve-
ment in HH joint damage [19].
Patients with HH have shown disc degeneration and calcifications in the intervertebral discs
due to calcium pyrophosphate crystal deposits [20]. In a retrospective study [21], one third of
patients with HH showed spine arthropathy on radiography. The literature contains no data
on the prevalence of low back pain in patients with a clinical phenotype of HH. Both our geno-
type groups showed similar self-reported prevalence of low back pain and sciatica, which sug-
gests that the lumbar spine involvement in HH is independent of the genotype.
We found an increased prevalence of OP, along with increased prevalence, although not sig-
nificant, of vertebral fractures in homozygote patients. Again, this observation could be related
to the increased iron overload observed in C282Y homozygotes. Indeed, the impact of the ge-
notype on the prevalence of OP was no longer significant when we adjusted for ferritin concen-
tration. Several reports have shown that HH patients, particularly males, are at increased risk
of OP, which might be related to iron overload [1, 22].
The pathophysiology of OP in HH is not entirely clear. Animal and in vitro data support
that iron excess can affect bone formation and remodeling [1]. Iron-overloaded mice show in-
creased level of reactive oxygen species, serum tumor necrosis factor α and interleukin 6, asso-
ciated with severity of iron overload [23]. HFE-/- mice show impaired bone microarchitecture
and increased osteoclast number [24]. In vitro, iron disrupts the formation of hydroxyapatite
crystals and inhibits the proliferation and differentiation of osteoblasts [1].
There are several limitations and caveats to this study. Patients were asked to remember
symptoms or fractures attributed to hemochromatosis, which might suggest recall bias. As for
all surveys, this study may lack robust internal validity. Because of the relatively low number of
patients with compound heterozygosity, the number of rare events such as fractures or joint re-
placement surgery was low in this group, which might explain the non-significant findings for
joint replacement and fracture. Finally, we could not differentiate symptomatic and
asymptomatic fractures.
Conclusions
To conclude, this is the first study to compare the effect of genotype on HH-related musculo-
skeletal symptoms. C282Y homozygosity may confer increased risk of OA and OP as compared
with C282Y/H63D compound heterozygosity.
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Biotério – Pavilhão I, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal 
 Email: slmarques@ualg.pt; http://www.cbme.ualg.pt/bioterio_cbme.html 








das! condições! abaixo! discriminadas,! será! concedida! a! permissão! para! o! uso! de! animais! em!
experimentação! animal! ao! estudante! António! Camacho,! no! âmbito! do! seu! projecto! de!
doutoramento.!
1.! Numa! primeira! deslocação! ao! Biotério,! será! feito! o! acompanhamento! do! estudante! nas!
instalações,! e! serão! introduzidas! as! questões! éticas! relacionadas! com! o! uso! de! animais! em!
investigação! nomeadamente! ! as! regras! básicas! de! alojamento! dos! animais! de! modo! a! causar! o!
mínimo! impacto! negativo! aos! animais,! consoante! a! legislação! em! vigor,! bem! como! as! regras! de!
utilização!básicas!do!Biotério.!
2.! Durante! esta! visita,! e! outras! se! necessário,! será! assegurado! que! o! investigador! tem! as!
competências!mínimas!exigidas!no!uso!de!animais!experimentais.!
3.!Será!feita!a!análise!do!projecto!de!investigação!e!da!sua!metodologia!nomeadamente!no!que!diz!
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